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ABSTRACT OF DISSERTATION

ALTERATIONS IN GABAERGIC NTS NEURON FUNCTION IN ASSOCIATION
WITH TLE AND SUDEP

Epilepsy is a neurological disorder that is characterized by aberrant electrical
activity in the brain resulting in at least two unprovoked seizures over a period
longer than 24 hours. Approximately 60% of individuals with epilepsy are
diagnosed with temporal lobe epilepsy (TLE) and about one third of those
individuals do not respond well to anti-seizure medications. This places those
individuals at high risk for sudden unexpected death in epilepsy (SUDEP). SUDEP
is defined as when an individual with epilepsy, who is otherwise healthy, dies
suddenly and unexpectedly for unknown reasons. SUDEP is one of the leading
causes of death in individuals with acquired epilepsies (i.e. not due to genetic
mutations), such as TLE. Previous studies utilizing genetic models of epilepsy
have suggested that circuitry within the vagal complex of the brainstem may play
a role in SUDEP risk. Gamma-aminobutyric acid (GABA) neurons of the nucleus
tractus solitarius (NTS) within the vagal complex receive, filter, and modulate
cardiorespiratory information from the vagus nerve. GABAergic NTS neurons then
project to cardiac vagal motor neurons, eventually effecting parasympathetic
output to the periphery. In this study, a mouse model of TLE was used to assess
the effect of epileptogenesis on GABAergic NTS neuron function and determine if
functional alterations in these neurons impact SUDEP risk. It was discovered that
mice with TLE (i.e. TLE mice) have significantly increased mortality rates
compared to control animals, suggesting that SUDEP occurs in this model. Using
whole cell electrophysiology synaptic and intrinsic properties of GABAergic NTS
neurons were investigated in TLE and control mice. Results suggest that during
epileptogenesis, GABAergic NTS neurons become hyperexcitable, potentially due
to a reduction in A-type potassium channel current and increased excitatory
synaptic input. Increases in hyperexcitability have been shown to be associated
with an increased risk of spreading depolarization and action potential inactivation
leading to neuronal quiescence. This may lead to a decreased inhibition of
parasympathetic tone, causing cardiorespiratory collapse and SUDEP in TLE.
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Chapter 1 Introduction
1.1 Sudden unexpected death in epilepsy
1.1.1 History and Definitions
The International League Against Epilepsy defines epilepsy as when an
individual has at least two unprovoked seizures occurring greater than 24 hours
apart (Fisher et al., 2014). It has been well-established that death in individuals
with epilepsy can be attributed to the epilepsy itself or to a seizure that is unable
to stopped by medication (Mackenzie Bacon, 1868; Spratling, 1902; Munson,
1910; Hauser et al., 1980; Nashef and Brown, 1996; Nashef and Sander, 1996).
According to the Centers for Disease Control, about 1.2% of the United States
population have epilepsy, which amounts to about 3.4 million individuals
nationwide. Individuals with epilepsy have a 2.5-fold increase in the risk for sudden
death compared to a healthy individual (Shackleton et al., 1999). One of the
leading causes of death in individuals with epilepsy is sudden unexpected death
in epilepsy (SUDEP) (Nashef, 1997; Nashef et al., 1998; Kloster and Engelskjon,
1999; Lhatoo and Sander, 2005; Tomson et al., 2008; Tolstykh and Cavazos,
2013; Ellis and Szabo, 2018). Case studies of SUDEP first appear in the literature
in the early 1970’s via investigation of death certificates of individuals with epilepsy
(Hirsch and Martin, 1971). Up until the use of translational animal models of
epilepsy, SUDEP research focused on postmortem investigations and singlepatient case studies (Terrence et al., 1975; Sarkioja and Hirvonen, 1984; Leestma
et al., 1989; Dasheiff, 1991). By the mid-1990’s SUDEP research experienced a
resurgence, and several definitions of SUDEP were developed.
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The definition of SUDEP, first published in 1997, is: “sudden, unexpected,
unwitnessed or witnessed, non-traumatic and non-drowning death in patients with
epilepsy, with or without status epilepticus, in which postmortem examination does
not reveal a toxicologic or anatomic cause for death” (Nashef, 1997). More
recently, the definition has been slightly modified to include that the death was not
directly caused by a seizure (Annegers, 1997; Annegers and Coan, 1999). SUDEP
cases are also divided into four categories: definite, probable, possible, and
unlikely SUDEP (Annegers, 1997). Definite SUDEP meets all the definition criteria
and has a description of the circumstances of death. Probable SUDEP meets the
criteria but does not have postmortem information. Possible SUDEP includes
cases where SUDEP cannot be ruled out, but also cannot be sufficiently confirmed
based on medical records. Unlikely SUDEP includes deaths for which other causes
are clearly established or circumstances make SUDEP improbable (Annegers,
1997). It can be difficult to ascertain if individuals with epilepsy have died from
SUDEP because most individuals are not continuously monitored in the home
setting. Presently, it is difficult to accurately identify individuals at risk for SUDEP
and research has yet to identify underlying biomarkers for and mechanisms of
SUDEP.
1.1.2 Patient Characteristics
The incidence of SUDEP in the United States is about 1.2 out of every 1000
individuals with epilepsy (Harden et al., 2017). Early studies examining individuals
with epilepsy focused on potential cardiac and respiratory abnormalities.
Individuals with epilepsy that are not previously diagnosed with a cardiac pathology
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have an increased heart rate and electrocardiographic (ECG) abnormalities (e.g.
QT lengthening) (Drake et al., 1993). Individuals with epilepsy were also shown to
have apnea during a generalized tonic-clonic seizure (GTCS) (Fish, 1997). As
early as 1987, it was hypothesized that autonomic nervous system imbalance,
cardiac arrhythmia, and epilepsy may be linked (Lathers et al., 1987).
There have been many studies assessing potential risk factors for SUDEP
in individuals with epilepsy. The risk for SUDEP has been well-established to
increase with the duration of epilepsy, seizure severity, and seizure frequency
(Ficker et al., 1998; Sperling, 2001; Devinsky, 2011), potentially because these
individuals have a longer history of seizure events. It has been shown that the
frequency of GTCS is strongly associated with SUDEP risk, regardless of the
number of medications the individual has previously been prescribed (Lamberts et
al., 2012). Therefore, it is crucial to decrease seizure frequency in order to
attenuate SUDEP risk. However, not all individuals with epilepsy have seizures
that are well-controlled with the first medication they are prescribed. Often,
treatment with two or three medications is necessary before seizure frequency
decreases. Even so, about 30% of individuals are unable to resolve their seizures
by medication or surgery and have refractory epilepsy. This patient population is
one of the highest at risk for SUDEP (Devinsky, 2011; Tolstykh and Cavazos,
2013; Thurman et al., 2014). Another patient risk factor is compliance with antiepileptic medications (AEMs). It has been shown that if an individual with epilepsy
does not follow their treatment regimen, their risk for seizures increases, thus
increasing the risk for SUDEP. The environment in which a patient sleeps may also
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play a role in increasing the likelihood of SUDEP. Patient studies have shown that
individuals who have suffered from SUDEP, tend to have a lack of nighttime
supervision and tend to be found in the prone position (Devinsky, 2011).
Autonomic imbalance relating to cardiorespiratory function in epilepsy
patients may also be a risk factor for SUDEP. A study examining data from epilepsy
monitoring units (EMUs) world-wide found that many individuals that suffered from
SUDEP experienced respiratory abnormalities such as apnea (Ryvlin et al., 2013).
During a seizure event, individuals with epilepsy have displayed cardiac
arrhythmias, postictal bradycardia, and asystole (Surges and Sander, 2012).
Additionally, some individuals have displayed lengthy postictal EEG suppression
(PGES), characterized by a flat-lining of the electroencephalogram (EEG) after a
seizure event. These individuals have a higher risk for SUDEP compared to those
with shorter PGES (Lhatoo et al., 2010a; Surges et al., 2010). However, specific
mechanisms that elucidate these risk factors or identify biomarkers for SUDEP
remain to be established.
1.2

Suggested Mechanisms of SUDEP
In the past 5-10 years there has been an increased amount of research

focused on potential mechanisms of SUDEP. Many of these studies utilize
genetic mouse models of SUDEP, which will be further detailed in a following
section. Dlouhy et al. hypothesized that a generalized tonic-clonic seizure
(GTCS) spreads to three areas eventually resulting in SUDEP: the midbrain,
respiratory centers and brainstem cardiovascular centers (Dlouhy et al., 2016).
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1.2.1 The Midbrain
The midbrain is a portion of the central nervous system that is associated
with vision, hearing, motor control, wakefulness, arousal, and temperature
regulation. It contains the following structures: tectum, tegmentum, cerebral
aqueduct, and peduncles. It adjoins to the pons, cerebellum, thalamus, and
hypothalamus. Upon spread to the midbrain, seizures inhibit the ascending arousal
system, located in the brainstem, which plays a role in sleep-wake consciousness
(Dlouhy et al., 2016). Individuals with epilepsy that have suffered from SUDEP are
often found lying in the prone position and researchers have hypothesized that this
is due to dysfunction within the arousal system (Langan et al., 2000; Ryvlin et al.,
2013; Sowers et al., 2013; Ellis and Szabo, 2018). The ascending arousal system,
or ascending reticular activating system (ARAS), originates in the upper brainstem
and is involved in regulating sleep-wake transitions via its interaction with the
ventrolateral preoptic nucleus (VLPO). The primary neurotransmitter in the VLPO,
γ-aminobutyric acid (GABA) inhibits ARAS during sleep. Interactions between the
VLPO and ARAS maintains a sleep-wake switch (Edlow et al., 2012). In individuals
with epilepsy this switch may malfunction, which could be an underlying factor in
the correlation between nighttime seizures, inability to wake up at that time, and
SUDEP (Lamberts et al., 2012; Sowers et al., 2013; Gumusyayla et al., 2016).
Additionally, patients with epilepsy show dysfunction in the ARAS when measured
via polysomnography and magnetic resonance imaging (MRI) (Gumusyayla et al.,
2016; Englot et al., 2017b). Dysfunction within the arousal system does put
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individuals with epilepsy at a higher risk for SUDEP but the neuronal mechanisms
that contribute to this dysfunction remain to be elucidated.
1.2.2 Postictal EEG Suppression
PGES is defined as the absence of EEG activity (i.e. less than 10 µV in
amplitude allowing for muscle movement, breathing, and electrode artifacts)
(Lhatoo et al., 2010a). PGES is characterized by a short collapse of cardiac and
respiratory rates post-seizure. There have been several studies examining patient
incidence of PGES in association with seizures and SUDEP. An early study did a
post-hoc examination of video EEG of individuals with epilepsy, some of whom
went on to die of SUDEP (Lhatoo et al., 2010a). Fifty percent of patients had PGES
following a seizure and its duration was significantly longer in the individuals that
eventually died of SUDEP (Lhatoo et al., 2010a). Another study examined the
association between PGES, seizure type, and SUDEP. While they found that
PGES occurred postictally, neither the presence nor duration of PGES was
significantly associated with SUDEP as an independent risk factor (Surges et al.,
2011). Another study concluded that PGES is not related to seizure duration or
severity, but that it is related to oxygen desaturation during a seizure (Seyal et al.,
2012). Lee et al. did a retrospective analysis of heart rate and PGES in individuals
with nocturnal seizures and also found that PGES did not impact SUDEP risk (Lee
et al., 2013). Similarly, Lamberts et al., found that PGES was not significantly
correlated with autonomic instability but did find an association with nocturnal
seizures (Lamberts et al., 2013). Kuo et al., monitored patients with GTCS for
PGES and found that it was not associated with seizure phase or duration (Kuo et
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al., 2016). However, another study found that PGES duration was increased when
seizure onset occurred during sleep (Peng et al., 2017). Contradictory to the
previously mentioned studies, it was recently found that individuals that died of
SUDEP had a shorter, not longer, PGES duration in association with SUDEP risk
(Kang et al., 2017). Overall, the evidence regarding whether PGES is related to
SUDEP remains inconclusive. However, alterations in both the arousal system and
PGES in SUDEP have led researchers to postulate that the serotonergic system
(5-HT), in addition to the respiratory centers may play a role.
1.2.3 Respiratory Centers
Recently respiratory dysfunction has been more closely examined as a
potential mechanism for SUDEP because hypoxia, apnea, and other respiratoryrelated dysfunction have been shown to occur during seizures. (Watanabe et al.,
1982; Coulter, 1984; James et al., 1991). Recently, respiratory dysfunction has
been more closely examined as a potential mechanism for SUDEP. Nelson and
Ray in 1968 published one of the first accounts of respiratory arrest after seizure
but it was not until 1999 that parameters were published to monitor these changes
in individuals with epilepsy (Fish, 1997). Apnea (i.e. temporary cessation of
breathing) occurs in 100% of generalized seizures and since it is associated with
hypoxia, researchers concluded that respiratory function should be monitored in
epilepsy patients (Fish, 1997). In 1996, Nashef et al. showed that greater than 50%
of patients had apnea in concert with seizures (Nashef et al., 1996). Additionally,
these respiratory parameters are associated with impaired ventilation, O2
desaturation, and hypoxia (Blum et al., 2000; Sowers et al., 2013). O2 saturation
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has been shown to drop to below 90% in some individuals and the longer a seizure
lasts, the lower saturation becomes. In what is thought to be a seminal study by
Ryvlin et al., respiratory and cardiac data from international EMUs was examined
in cases where individuals died of SUDEP (Ryvlin et al., 2013). One of their major
conclusions was that SUDEP was preceded by terminal apnea, followed by cardiac
arrest and death (Ryvlin et al., 2013). This study is problematic for several reasons,
one of which being that all respiratory measurements were done by visual
inspection of EMU patient videos. No quantitative measurements were taken and
no mention is made regarding the quality of the video or how visible the lack of
respiratory movement was. Additionally, there was no effort made to resuscitate 5
out of the 16 patients that died of SUDEP. It was also not stated if individuals in
this study had been previously diagnosed with any pulmonary dysfunction, which
may have played a role in SUDEP.
Stimulation of higher brainstem centers to elicit seizures has been shown
to be associated with respiratory depression. Stimulation in the orbital frontal
cortex, temporal lobe, and amygdala can result in respiratory depression and
central apnea (Kaada and Jasper, 1952; Bonvallet and Bobo, 1972). More
recently, high resolution brain mapping has shown that seizures originating in the
frontotemporal region, spread to the amygdala, eliciting central apnea (Dlouhy et
al., 2015). Interestingly, during these procedures individuals were awake, but not
aware that the apnea occurred. These data suggest that seizures may spread to
and affect brain regions that are crucial for basic functions. There are other higher
brain pathways that project downstream; for example, the temporal lobe connects
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to respiratory centers (Bateman et al., 2010a; Faingold et al., 2010; Faingold,
2012). While these areas and the spread of seizures to respiratory nuclei may be
involved in SUDEP, the neurons in these brain regions have yet to be directly
examined in this context. In examining respiratory function and SUDEP, there are
few studies that make direct measurements of breathing, so this potential
mechanism remains poorly understood. One of the things that PGES and
respiratory function have in common is signaling through serotonergic/5hydroxytryptamine (5-HT) neurons (Ellis and Szabo, 2018).
1.2.4 5-HT Neurons
5-HT is a monoamine neurotransmitter that is primarily found within the
raphe nuclei of the brainstem (Jacobs and Azmitia, 1992; Sowers et al., 2013). 5HT neurons receive connections from a wide variety of regions, including the
cortex, hypothalamus, and brainstem, and projects to many regions within the
central nervous system (Sowers et al., 2013). 5-HT is involved in many brain
functions, such as respiration, arousal, anxiety, depression, and central
chemoreception (Sowers et al., 2013; Kennedy and Seyal, 2015). Since 5-HT
neurons stimulate respiration and arousal, dysfunction in this system has been
hypothesized to sudden death (Richerson and Buchanan, 2011).
The Pre-Bötzinger complex (BPC) in the brainstem is responsible for
breathing, hypoxia, and gasping responses. The proper function of the BPC is
dependent on 5-HT receptor activation by serotonin (Richerson, 2004; Hodges and
Richerson, 2010; Massey et al., 2014). In mice where 5-HT receptors are deleted,
they have apnea, increased mortality, and defects in arousal (Hodges et al., 2008;
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Hodges et al., 2009; Buchanan et al., 2014). A separate study examined neuronal
inhibition of 5-HT neurons with Designer Receptors Exclusively Activated by
Designer Drugs (DREADDs) and found that ventilation was significantly blunted
(Ray et al., 2011). Medullary 5-HT neurons act as chemoreceptors and respond to
small changes in physiologic pH (Wang et al., 1998; Wang et al., 2001c; Richerson
et al., 2005; Corcoran et al., 2009). Increased firing of 5-HT neurons increases
respiratory output (Ptak et al., 2009). 5-HT neurons in the midbrain act as
chemoreceptors by inducing arousal in response to changes in arterial carbon
dioxide, which has been hypothesized to be defective in SUDEP. It is postulated
that after a seizure, the individual would be unresponsive as the pillow blocks the
airway and being unable to relieve the obstruction would result in hypoxia and
death (Sowers et al., 2013). Earlier work with animals that lack the 5-HT2C receptor,
provides evidence of serotonin’s involvement with SUDEP, as these mice suffer
from respiratory depression and mortality (Brennan et al., 1997). In the DBA/2
mouse, administration of a selective serotonin reuptake inhibitor (SSRI) reduces
respiratory depression and mortality (Tupal and Faingold, 2006). These mice also
have abnormal 5-HT receptor expression in the brainstem (Uteshev et al., 2010).
In some individuals with epilepsy, SSRIs reduced the incidence of seizure-induced
apnea (Bateman et al., 2010b; Dlouhy et al., 2016). The SSRI fluoxetine has also
been shown to prevent respiratory arrest in the DBA/2 and DBA/1 mouse models
(Faingold et al., 2011b; Faingold et al., 2011a). There are several AEMs that also
increase 5-HT extracellular concentrations as a by-product of their function (Bagdy
et al., 2007). Previous studies have also shown that there is a decrease in 5-HT1A
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receptor binding in individuals with epilepsy (Toczek et al., 2003; Savic et al., 2004;
Richerson and Buchanan, 2011). However, there is no evidence of 5-HT gene
mutations in patients that are directly linked to epilepsy (Richerson and Buchanan,
2011). In 2016, Zhan et al. showed a decrease in 5-HT neuronal firing in the
medullary raphe after an electrically induced seizure (Zhan et al., 2016). While this
study was able to show a direct link between a single seizure and 5-HT function,
individuals at risk for SUDEP have a history of seizures. This study does not
address the potential effect multiple seizures, over a period of time, has on 5-HT
function and subsequent respiratory output. Another study examined postictal
serotonin levels in individuals with epilepsy. They found that serum serotonin was
significantly increased post-GTCS compared to interictal levels, suggesting that 5HT is acutely altered post-seizure. While it appears that 5-HT is generally involved
in epilepsy, it is does not conclusively cause of SUDEP. Further work needs to be
done in brainstem regions to provide direct evidence of 5-HT and SUDEP.
1.2.5 Cardiac and Autonomic Dysfunction
Another focus of potential SUDEP mechanisms are cardiac and autonomic
changes in relation to epilepsy that may contribute to sudden death. Peri-ictal
autonomic dysregulation in individuals with epilepsy has been published as early
as 1972 by Gastaut (Gastaut, 1972). The autonomic nervous system is responsible
for regulating sympathetic and parasympathetic output to the periphery, including
partially modulating cardiac activity. Information regarding cardiac function and
blood pressure is relayed to the brainstem via the afferent fibers of the vagus
nerve. Blood pressure changes are influenced primarily by the baroreceptor reflex,
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which involves baroreceptors located on the carotid sinus and aortic arch. The
baroreceptors travel up the afferent fibers of the vagus nerve, directly to neurons
within the brainstem, in a region called the nucleus tractus solitarius (NTS).
Excitatory NTS neurons synapse to the caudal ventrolateral medulla (CVLM),
which projects to the rostral ventrolateral medulla (RVLM), inhibiting those
neurons. As the primary regulator of sympathetic output to the periphery, the
RVLM projects glutamatergic fibers to sympathetic preganglionic neurons in the
spinal cord. When blood pressure increases, the baroreceptors are activated and
the NTS increases excitatory neurotransmission to the CVLM, inhibiting the RVLM,
decreasing excitatory neurotransmission to the heart and decreasing blood
pressure. When blood pressure is low, the baroreceptors receive less tonic
activation and the sympathetic output increases to maintain a steady blood
pressure. GABAergic NTS neurons synapse to cardiac vagal motor neurons
(CVMNs) in the nucleus ambiguus (NA) and the dorsal motor nucleus of the vagus
(DMV) to regulate vagal tone, slowing heart rate. This is further increased when
blood pressure is high. It is important to note that the circuitry relating to the
parasympathetic nervous system is primarily directed toward regulating heart rate
(Gordan et al., 2015).
With regard to cardiac function, the sympathetic nervous system serves to
increase heart rate and myocardial contractility under various pathological
conditions. The parasympathetic nervous system serves to reduce heart rate and
functions primarily during sleep or resting conditions. An additional factor in heart
rate that is influenced by the autonomic nervous system is heart rate variability
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(HRV), which is defined as the variation in the time between each heartbeat.
Clinically, two measures of HRV are the standard deviation between the R-R
intervals (SDNN) and the root mean squared of the R-R interval (RMSSD) (Stein
and Kleiger, 1999). The SDNN is interpreted as the general HRV and the RMSSD
as the parasympathetic or vagal tone component of HRV (Shaffer and Ginsberg,
2017). Studies examining individuals with epilepsy in association with cardiac
function have focused primarily on changes in blood pressure, heart rhythms, and
HRV as potential mechanisms of SUDEP. There have been a paucity of studies
investigating blood pressure changes as a potential mechanism for SUDEP. The
first paper was a patient case study which examined an individual with epilepsy
and measured systolic, diastolic, and mean arterial blood pressure. In this case, a
GTCS during sleep increased blood pressure measurements, and the patient
showed a period of post-ictal hypotension that concluded with PGES (Bozorgi et
al., 2013). Since this patient had no prior history of cardiac dysfunction, this study
suggests that the seizure had an impact on autonomic control of blood pressure.
It would have been more impactful to measure interictal blood pressure to see if it
is altered without a seizure event as a measure of autonomic dysfunction. Another
study compared awake interictal blood pressure and heart rate in individuals that
eventually died of SUDEP to refractory and AEM controlled individuals (Nei et al.,
2016). Their retrospective analysis showed that there was a trend towards an
increase in diastolic blood pressure in individuals who eventually died of SUDEP
(Nei et al., 2016). However, the authors only used heart rate and blood pressure
measurements from the three most recent outpatient visits and available peri-
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mortem data was not reported. Another study measured mean arterial blood
pressure, heart rate, and O2 saturation in individuals with focal and bilateral
seizures (Hampel et al., 2016). This study found no changes in O2 saturation but
mean arterial blood pressure was increased (Hampel et al 2016). However, they
did not state if this change was post-seizure, and therefore cannot make
conclusions regarding autonomic changes related to seizure activity. Conflictingly,
another study by the same group found that there were no alterations in the
baroreflex response in individuals with focal seizures (Hampel et al., 2017). While
the data suggest that blood pressure and baroreflex sensitivity is altered in
individuals with epilepsy, it has not been shown that these changes cause SUDEP.
More work needs to be done where blood pressure and the baroreflex response
are consistently monitored in individuals with epilepsy over time.
Epilepsy researchers have also hypothesized that autonomic dysfunction
manifesting itself as a change in HRV, arrhythmia, tachycardia, asystole,
bradycardia, and QT lengthening, occurring pre-ictally, ictally, post-ictally, and
peri-ictally contribute to SUDEP (Stollberger and Finsterer, 2004; Massey et al.,
2014; Bermeo-Ovalle et al., 2015). However, in many of these patients, information
regarding prior cardiovascular disease diagnoses or medications is often lacking,
making it difficult to account for confounding variables.
Several forebrain structures including the hippocampus, medial frontal
cortex, and hypothalamus are involved in seizure networks and autonomic output
(Cechetto and Chen, 1990). These areas project to the brainstem, regulating
sympathetic and parasympathetic function. HRV is primarily dependent on vagal
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tone and modulates heart rate in response to breathing, activity, wakefulness, and
sleep (Hartikainen et al., 1996; Stein and Kleiger, 1999; Gordan et al., 2015;
Shaffer and Ginsberg, 2017). In addition to the SDNN and RMSDD (i.e. time
domain parameters), HRV can be analyzed via frequency domain parameters (i.e.
low frequency, high frequency) (Stein and Kleiger, 1999). The frequency domain
provides information regarding the amount of variance in heart rhythms explained
by oscillations in heart rate at various frequencies allowing for the interpretation of
autonomic balance (Stein and Kleiger, 1999). High frequency (HF) power is
mediated by vagal tone and respiratory sinus arrhythmia, while low frequency (LF)
power is mediated by a combination of parasympathetic tone, sympathetic tone,
and the baroreflex response (Hyndman et al., 1971; Pomeranz et al., 1985; Fallen
et al., 1988; Stein and Kleiger, 1999; Jansen and Lagae, 2010). There have been
several studies that found alterations in measurements of HRV in individuals with
epilepsy and concluded that it may be associated with SUDEP (Harnod et al.,
2008; DeGiorgio and DeGiorgio, 2010; Toth et al., 2010; Lotufo et al., 2012; Sarkis
et al., 2015; Sivakumar et al., 2016; DeGiorgio et al., 2017; Stollberger and
Finsterer, 2017). The majority of these studies have found either a decrease in
vagal tone with an increase in sympathetic drive after a GTCS (Sarkis et al., 2015;
Sivakumar et al., 2016), with one study finding that this persisted 5-6 hours postseizure (Toth et al., 2010). When examining inter-ictal HRV, the research shows
that time and frequency domain measures are lower, suggestive of a reduction in
vagal tone and long-term autonomic imbalance in individuals with epilepsy
(Ansakorpi et al., 2000; Ansakorpi et al., 2002; Harnod et al., 2008). These data
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also suggest that epilepsy impacts autonomic function outside of the pre-ictal, ictal,
and post-ictal periods. There have also been a few studies stating that there is no
association between autonomic dysfunction, epilepsy, and SUDEP (Persson et al.,
2007; Lee et al., 2013). One study found that while there was a decrease in heart
rate just prior to a nighttime seizure, there were no post-ictal changes in heart rate,
leading to the conclusion that there was no evidence that SUDEP is associated
with postictal autonomic dysfunction (Lee et al 2013). Additionally, an older study
found that there were no changes in time or frequency measurements in
individuals with untreated epilepsy (Persson et al., 2007). There was another study
that examined respiratory sinus arrhythmia (RSA) and heart rate in adolescents
with epilepsy and found that in 5 of the non-epileptic individuals had increased
RSA and decreased heart rate, suggestive of autonomic imbalance and were later
diagnosed with epilepsy (Sivakumar et al., 2016). This suggests that autonomic
dysfunction may precede the onset of epilepsy and may be a useful predictive
marker for SUDEP. Many studies have also found changes in cardiac function in
individuals with epilepsy who have not been diagnosed with any prior cardiac
dysfunction (Surges et al., 2010; Velagapudi et al., 2012; Massey et al., 2014;
Dlouhy et al., 2016). While overall, the data suggest that autonomic and cardiac
dysfunction occurs in individuals with epilepsy, alterations in the function of
brainstem neurons that regulate autonomic output should be investigated to
determine if changes in their function are associated with autonomic imbalance
and SUDEP.
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1.3

Genetic Models of SUDEP
1.3.1 Dravet’s Syndrome
Developing genetic models of epilepsy where the animals suffer from

SUDEP has been popular due to the ease of gene deletion that leads to a seizure
phenotype. Two of the most well-established models are the Dravet’s syndrome
(DS) and the KCNA1-null mouse. DS is an epilepsy channelopathy characterized
by mutations in the voltage-gated Na+ channel, Nav1.1, which is encoded by the
SCN1A gene. There are several different mutations in the SCN1A gene can that
lead to altered function in Nav1.1 and epilepsy. These mutations can occur in the
regions of the gene that encode for any part of the six transmembrane spanning
unit that comprises the channel and/or on the C- and N-termini (Catterall et al.,
2010; Catterall, 2012). Additionally, complete deletion of SCN1A in humans and
mice is embryonically lethal (Catterall et al., 2010). These mutations can be
responsible for various forms of inherited epilepsies, including DS (Escayg et al.,
2000; Catterall et al., 2010). Individuals with DS suffer from SUDEP and display
depressed HRV and abnormal cardiac rhythms (Le Gal et al., 2010; Delogu et al.,
2011; Sakauchi et al., 2011; Goldman et al., 2016). In mouse models, the mutation
known to cause Dravet’s Syndrome in humans was introduced into the SCN1A
gene to create reduced Nav1.1 channel function, subsequently leading to a
spontaneous seizure phenotype (Yu et al., 2006; Oakley et al., 2009; Oakley et al.,
2011; Cheah et al., 2012; Auerbach et al., 2013; Kalume et al., 2013; Ogiwara et
al., 2013; Aiba and Noebels, 2015). In this model, mice begin to have spontaneous
seizures by postnatal day 21 and sudden death begins to occur around postnatal
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day 23 (Yu et al., 2006; Ogiwara et al., 2007; Cheah et al., 2012; Kalume et al.,
2013). DS mice have a decrease in the density of GABA interneurons, reduced
Na+ current, and action potential firing without any changes in excitatory neurons
(Yu et al., 2006; Cheah et al., 2013). The imbalance between inhibition and
excitation may be responsible for the seizure phenotype. Additionally, these mice
display altered cardiorespiratory function, such as QT prolongation, bradycardia,
suppressed inter-ictal HRV, and gasping (Kalume et al., 2013; Aiba and Noebels,
2015). It has been hypothesized that significant post-ictal bradycardia due to
increased vagal tone contributes to SUDEP in DS (Kalume et al., 2013). This
model implicates the involvement of central autonomic neurons, because animals
have cardiac dysfunction, even in a GABA forebrain neuron specific knockout
(Kalume et al., 2013). Additionally, causing seizures to spread from the cortex to
brainstem leads to cardiorespiratory collapse and sudden death (Aiba and
Noebels, 2015). This model has provided significant insight into potential
mechanisms for SUDEP, but it only affects a small percent of the total epilepsy
population.
1.3.2 Potassium Channel Mutations
Another common genetic model of epilepsy is the KCNA1-null mouse
model. This involves the deletion of the KCNA1 gene that encodes the Kv1.1
voltage-gated K+ channel (Glasscock et al., 2010; Moore et al., 2014; Gautier and
Glasscock, 2015; Simeone et al., 2018). Kv1.1 is expressed in the brain and the
vagus nerve (Glasscock et al., 2010; Glasscock et al., 2012; Glasscock, 2013;
Goldman et al., 2016). In addition to displaying an epilepsy phenotype, Kv1.1
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knockout mice die suddenly and prematurely (Smart et al., 1998; Glasscock et al.,
2007; Glasscock et al., 2010). They also have a high frequency of atrio-ventricular
(AV) blocks that can be prevented by atropine administration, suggestive of
autonomic imbalance (Glasscock et al., 2010). Additionally, Kv1.1 mice display
hyperexcitability in axons from the mouse vagus nerve, indicative of increased
excitatory transmission to central autonomic neurons (Glasscock et al., 2012).
These mice also have increased respiratory drive and apnea (Simeone et al.,
2018). Although this study showed that respiratory dysfunction occurs in Kv1.1
knockout mice, the authors did not show that sudden death occurred in concert
with respiratory dysfunction. Researchers have also shown that increased
activation of KCNQ2, which encodes the Kv7.2 potassium channel, in vagal nerve
fibers rescues hyperexcitability seen in Kv1.1 knockout mice (Glasscock et al.,
2012) and that SCN2A deletion improves survival rates in Kv1.1 knockout mice
(Mishra et al., 2017).
Another genetic epilepsy model for SUDEP introduces a mutation into
KCNQ1 gene that encodes the Kv7.1 channel, one of the most common genes for
long-QT syndrome in humans. Individuals with long-QT are at high risk for sudden
death due to their propensity to have fatal ventricular arrhythmias (Goldman et al.,
2016). When a dominant point mutation is introduced into the gene, it reproduces
the human phenotype and these mice display dysfunctional neuronal
repolarization, seizures, and sudden death (Goldman et al., 2009). The
examination of genes encoding voltage-gated K+ channels in the brain and the
heart has provided valuable insight into how their dysfunction contributes to
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epileptogenesis, autonomic dysfunction and SUDEP, however it is difficult to
separate the genetic mutation from the seizures and sudden death.
1.3.3 Audiogenic Seizure Models
Researchers have used DBA/1 and DBA/2 mice to study mechanisms of
SUDEP because they are susceptible to seizures when exposed to high-intensity
acoustic stimulation (i.e. audiogenic seizures) (Faingold et al., 2010). Faingold et
al. has shown that an audiogenic seizure leads to respiratory arrest in 30% of these
mice (Faingold et al., 2010). However, this study did not complete any quantitative
respiratory measures and only visual assessment of the chest rising and falling
was done. Administration of SSRIs in these mice reduced the incidence of seizureinduced respiratory arrest (Tupal and Faingold, 2006; Zeng et al., 2015; Faingold
et al., 2016). These mice also displayed altered expression of 5-HT receptors in
the caudal brainstem (Uteshev et al., 2010). However, there are several pitfalls
with this model: 1) they do not develop spontaneous seizures; 2) mice sometimes
die after the first seizure, which does not meet the criteria for SUDEP; 3) It does
not appear that autonomic dysfunction has been examined in this model. While
genetic models of epilepsy have been informative to the field of SUDEP, they are
lacking in that they only apply to a very small percent of individuals with epilepsy.
Acquired epilepsies, (i.e. not caused by genetic mutations), affect a much larger
percentage of individuals with epilepsy who are at risk for SUDEP and acquired
epilepsy mouse models need to be utilized to determine biomarkers and
preventative options for these individuals as well.
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1.4

Acquired Epilepsies
1.4.1 Definitions and Epidemiology
Acquired epilepsies are broadly defined as a neurological disorder that is

initiated by some type of insult to the brain (Delorenzo et al., 2005; Dudek and
Staley, 2012). While epilepsy affects 1-2% of the population, about half of those
individuals have acquired epilepsy (Delorenzo et al., 2005; McNamara and
Scharfman, 2012). The other 50% of epilepsies are either idiopathic (i.e. no known
cause in the absence of brain abnormalities) or genetic (Delorenzo et al., 2005).
In acquired epilepsy, there is typically a known cause of the neurological insult that
induces a permanent change in a previously normal brain leading to the
development of epilepsy (Delorenzo et al., 2005). This occurs in 3 phases: the
initial insult, the latent period of epileptogenesis, and spontaneous recurrent
seizures (Delorenzo et al., 2005).
1.4.2 Temporal Lobe Epilepsy
The most common type of acquired epilepsy is TLE which affects 60% of
all individuals with epilepsy according to the Epilepsy Foundation. TLE involves an
imbalance in the excitatory and inhibitory networks within the temporal lobe. This
includes the hippocampus, amygdala, auditory cortex, and the entorhinal cortex.
TLE is form of partial or focal epilepsy that can be further split into 2 types: medial
TLE and neocortical TLE. Medial TLE is the most common of the two (TellezZenteno et al., 2005; McNamara and Scharfman, 2012). While there is little
research done on the epidemiology of TLE, the reported incidence is 10.4 per
100,000 individuals (Tellez-Zenteno and Hernandez-Ronquillo, 2012).
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1.4.3 Pathophysiology of TLE
As in acquired epilepsy, an initial insult followed by a latent period
culminates in recurrent seizure pathology (White, 2012). The pathogenesis of TLE
is progressive in nature and it is hypothesized that synaptic reorganization and a
disruption in the balance of excitation and inhibition play key roles in the
development of spontaneous seizures (Dudek and Staley, 2012). The death of
GABAergic interneurons directly following the insult and during the latent phase is
hypothesized to be responsible for decreases in GABA-mediated inhibition,
allowing for increases in network excitation (Kobayashi and Buckmaster, 2003;
Ben-Ari and Dudek, 2010; Dudek and Staley, 2012). Axon sprouting also
contributes to the development of increased excitation in TLE (de Lanerolle et al.,
1989; Sutula et al., 1989; Dudek and Staley, 2012), as the majority of these nerve
connections are excitatory.
1.5

Animal Models of TLE
1.5.1 Electrical Kindling
Kindling is a process that consists of daily electrical stimuli delivered to brain

structures such as the amygdala or hippocampus. When repeated over time, this
induces a generalized convulsive seizure and mice eventually develop a shorter
latency to seize as a response to stimulation. However, it is still debated if kindling
accurately reflects the human condition since rodents do not develop recurrent
spontaneous seizures (Loscher and Brandt, 2010). In terms of changes to cellular
pathology, increased recurrent excitation and altered GABA interneuron
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dysfunction does occur in this model (Lynch and Sutula, 2000; Sutula and Dudek,
2007; White, 2012).
1.5.2 Kainic-Acid Model
Kainic acid (KA) is an excitatory neurotransmitter agonist that activates
glutamate receptors and produces cell death via excitotoxicity when administered
to rodents (Cronin and Dudek, 1988). A single injection of KA leads to seizure
development in 50% of rats (Cronin and Dudek, 1988) and multiple low-dose
injections of KA leads to SE and subsequent TLE in 75-90% of rats (Hellier et al.,
1998; Hellier and Dudek, 2005; Williams et al., 2009). Recurrent neuronal
excitation and synaptic reorganization also occurs in this model. However, some
mouse strains, such as C57BL/6 and BALB/c mice, are more resistant to KAinduced cell death and degeneration at single and multiple injections
(Schauwecker and Steward, 1997; McKhann et al., 2003). Recurrent seizure
activity can reliably occur when KA is injected directly into the hippocampus
(Bouilleret et al., 1999), although this technique is more invasive than
intraperitoneal injections.
1.5.3 The Pilocarpine-Induced Status Epilepticus Model of TLE
The pilocarpine-induced status epilepticus (pilo-SE) model of TLE was
discovered to cause an initial period of severe seizures by Turski et al. in the early
1980’s. They observed that administration of pilocarpine results in a 1-2 hour
period of behavioral limbic seizures (Turski et al., 1983; Turski et al., 1984). It was
later found that following a latent period of 4-6 weeks, mice that developed SE,
also developed spontaneous seizures (Turski et al., 1989; Cavalheiro et al., 1994;
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Cavalheiro et al., 1996; Shibley and Smith, 2002; Winokur et al., 2004). About 3040% of mice develop SE from the pilocarpine injection, there is an ~30% mortality
rate, and the rest of the mice that do not have SE do not develop spontaneous
seizures (Shibley and Smith, 2002).
The pilo-SE model of TLE will be used in this dissertation because it more
accurately models the human form of TLE. Additionally, various mouse strains
reliably develop spontaneous seizures, whereas other models vary across strain
in terms of TLE development. It follows the previously set forth hypothesis of an
initial insult, followed by a latent period, and then spontaneous seizures.
Pilocarpine has been shown to induce cell death within a few days of
administration (Kobayashi and Buckmaster, 2003). Research has suggested
eventual development of recurrent seizures in this model is associated with
synaptic reorganization and aberrant sprouting in the hippocampus (Dudek and
Spitz, 1997; Dudek, 2002). Additionally, pilocarpine causes an insult in the same
structures within the temporal lobe that are affected in individuals with TLE. There
are mouse strain differences in the mortality and cell death in the hippocampus
following the pilocarpine treatment (Schauwecker, 2012). For the purposes of this
dissertation, mouse strains were used that have been well-established to develop
chronic spontaneous seizures or were monitored for seizure activity (Shibley and
Smith, 2002; Winokur et al., 2004; Bhaskaran and Smith, 2010b).
1.6

Significance of SUDEP in Individuals with TLE
About 60% of all individuals with epilepsy have TLE and about half of those

individuals have refractory TLE. Refractory TLE is defined by the Epilepsy
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Foundation as seizures that are not controlled by medications. In this case, the
individual has failed to become and stay seizure free with two or more trials of
AEMs. In fact, refractory epilepsy is one of the biggest SUDEP risk factors
(Tomson et al., 2008; Lhatoo et al., 2010b). Additionally, individuals with refractory
TLE have a higher frequency of seizures compared to those on AEMs, placing
them at an even higher risk for sudden death (Devinsky, 2011; Lamberts et al.,
2012; Tolstykh and Cavazos, 2013; Thurman et al., 2014).
There have been several studies showing that individuals with TLE have
cardiac and autonomic dysfunction. Increases in heart rate can occur in children
and adolescents with TLE (Mayer et al., 2004) and in newly diagnosed individuals,
who show ictal sympathetic overdrive, indicative of autonomic imbalance (Romigi
et al., 2016). While the evidence in patient studies is suggestive of autonomic and
cardiac dysfunction, it is conflicting as to whether this is associated with an
increase in sympathetic drive, a decrease in vagal tone or a combination of both
leads to autonomic imbalance. Many studies have found there to be an increase
in the time and frequency measurements of HRV, including impaired baroreflex
sensitivity potentially contributing to SUDEP risk (Dutsch et al., 2006; Romigi et
al., 2016). Others have observed a decrease in HRV, indicative of a decrease in
vagal tone (Massetani et al., 1997; Tomson et al., 1998; Ansakorpi et al., 2002;
Ronkainen et al., 2005; Jansen and Lagae, 2010; Surges et al., 2010; Suorsa et
al., 2011). HRV measurements seem to improve if TLE is controlled by medication
or surgery (Tomson et al., 1998; Hilz et al., 2002; Suorsa et al., 2011). Suorsa et
al. measured heart rate and HRV in individuals with TLE and in a follow-up study
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6 years later found that individuals with refractory TLE had decreased HRV over
time (Suorsa et al., 2011). This suggests that recurrent seizure activity has a
progressive effect on worsening autonomic imbalance. Many studies have also
found that individuals with TLE have ictal tachycardia, increased ictal and postictal heart rate, arrhythmia, and pathologic repolarization, suggestive of cardiac
dysfunction (Massetani et al., 1997; Jansen and Lagae, 2010; Surges et al., 2010).
HRV and vagal suppression may also have a circadian component, as individuals
with TLE have more pronounced HRV suppression at night compared to healthy
individuals (Ronkainen et al., 2005). Interestingly, no respiratory abnormalities
were found in individuals with TLE, but respiration was only measured in the interictal periods (Scorza et al., 2007). Additional evidence linking TLE to brainstem
dysfunction regulating autonomic output comes via functional MRI studies. There
was found to be lower connectivity from the temporal lobe to the ARAS and
brainstem in TLE individuals at high risk for SUDEP (Allen et al., 2017; Englot et
al., 2017a). Studies examining pilocarpine-induced SE in rodents also suggest
cardiac and autonomic imbalance occurs. In acute pilocarpine-induced SE, there
is an increase in heart rate and blood pressure in the hour following SE (Metcalf et
al., 2009b; Metcalf et al., 2009a). This suggests that an increase in sympathetic
drive occurs in the weeks following pilo-SE. Another study found altered autonomic
control of heart rate in rats 1-2 weeks after pilo-SE (Bealer et al., 2010). This
alteration in sympathovagal balance may increase the risk for arrhythmia and
sudden death. However, there has been a paucity of studies examining the effect
of spontaneous recurrent seizures in the pilocarpine-induced SE (i.e. pilo-SE)
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model of TLE in relation to SUDEP. The focus of this dissertation will be on the
association between the pilo-SE model of TLE, central autonomic dysfunction, and
SUDEP.
1.7

The Vagal Complex
1.7.1 Vagal Complex Anatomy
The vagal complex is located in the caudal brainstem and is a critical central

regulator of autonomic function. Viscerosensory inputs from the afferent fibers of
the vagus, glossopharyngeal, and facial nerves end in a bundle of primary sensory
fibers called the solitary tract (ST). The ST also conveys information from the
baroreceptors and chemoreceptors in the cardiovascular and respiratory systems.
The terminals of the ST release glutamate onto neurons within the nucleus tractus
solitarius (NTS). The NTS contains a heterogeneous population of both GABAergic
and glutamatergic neurons. These neurons serve as critical filters, integrators, and
modulators of sensory afferent information in order to regulate sympathetic and
parasympathetic output to the periphery. NTS neurons project their axons to
preganglionic parasympathetic motor neurons in the DMV and NA (Andresen and
Kunze, 1994; Doyle and Andresen, 2001; Wang et al., 2001a; Travagli et al., 2006;
Bailey et al., 2008). Glutamatergic neurons are responsible for the regulation of
sympathetic output of cardiac activity. Their axons project and synapse to inhibitory
neurons in the CVLM. CVLM neurons project to the RVLM, which send
glutamatergic fibers to preganglionic neurons in the spinal cord (Gordan et al.,
2015). Glutamatergic NTS neurons also regulate the DMV by providing phasic
excitation (Travagli et al., 1991; Gao and Smith, 2010).
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GABAergic NTS neurons maintain tonic inhibition that aids in the regulation
of vagal outflow (Davis et al., 2004; Travagli et al., 2006). About 20% of neurons
in the DMV influence the regulation of vagal tone to the periphery. The rest of the
GABA NTS neurons project to cardiac vagal motor neurons (CVMNs) in the
nucleus ambiguus (NA). CVMNs are motor neurons that synapse onto
postganglionic neurons in the cardiac ganglia at the base of the heart (Kunze and
Ritchie, 1990; Dergacheva et al., 2013). Vagal circuit plasticity has been shown to
occur in other disease states that affect autonomic regulation of homeostasis (Mei
et al., 2003; Bach et al., 2015; Boychuk et al., 2015a). It therefore stands to reason
that vagal complex neurons may have altered function in response to
epileptogenesis, especially since patient data suggests altered autonomic function
in TLE (Ronkainen et al., 2005; Romigi et al., 2016).
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Figure 1.1 Schematic of vagal complex circuitry.
NTS = nucleus tractus solitarius; DMV = dorsal motor nucleus of the vagus
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1.7.2 Characteristics of GABA NTS Neurons
GABAergic neurons make up a large proportion of NTS neurons and are
interspersed throughout the lateral and medial NTS (Blessing, 1990; Minson et al.,
1997; Fong et al., 2005). While GABA NTS neurons project to the DMV and NA,
they can also act as local interneurons, inhibiting NTS signaling (Davies et al.,
1987; Ezure and Tanaka, 1996; Davis et al., 2004; Kubin et al., 2006; Travagli et
al., 2006). The medial NTS tends to receive major input from arterial baroreceptors
(Andresen and Kunze, 1994; Andresen and Yang, 1995). Lateral NTS neurons
also play a role in respiratory regulation (Wasserman et al., 2002).
GABA is synthesized from glutamate via the enzyme glutamate
decarboxylase (GAD). GAD is present only in cells that use GABA as a
neurotransmitter (Simon et al., 1985; Erlander and Tobin, 1991; Roth and
Draguhn, 2012). Cytosolic GABA is shuttled into vesicles by vesicular GABA
transporter (VGAT), which is highly concentrated in presynaptic terminals
(Chaudhry et al., 1998; Jin et al., 2003). When a depolarization of the presynaptic
neuron prompts the release of the GABA into the synaptic cleft, GABA binds to
postsynaptic receptors, hyperpolarizing the postsynaptic neuron. GABA’s action is
terminated via reuptake into the presynaptic terminals and/or nearby glial cells.
Then GABA can be degraded by GABA transaminase into glutamate and succinic
semialdehyde (Roth and Draguhn, 2012).
GABA NTS neurons are important to many processes for autonomic
homeostasis as they are central integrators of peripheral cardiovascular,
respiratory, and gastrointestinal systems. GABA NTS neurons are able to directly

30

modulate heart rate, as microinjection of GABA antagonists into the NA decreases
heart rate (DiMicco et al., 1979; Wang et al., 2001a). GABA NTS neurons also play
a role in hypoxia and respiration (Accorsi-Mendonca et al., 2015), gastrointestinal
regulation, and glucose sensing (Browning et al., 2002; Bach and Smith, 2012;
Boychuk et al., 2015b; Boychuk et al., 2017).
1.8

Voltage-Gated K+ Channels
1.8.1 Structure and Function of Voltage-Gated K+ Channels
Voltage-gated K+ (Kv) channels are widely expressed in the brain and

throughout the central and peripheral nervous system (Coetzee et al., 1999;
Birnbaum et al., 2004; Villa and Combi, 2016). The human genome contains at
least 100 different Kv channel subunits (Cooper, 2012). All Kv channels and their
variants are built similarly with six transmembrane spanning (TM) domains. The
ion conducting pore is made up of four polypeptide domains arranged around a
central water-filled transmembrane region. There are four pore-forming segments
with intracellular N- and C-termini, 2 transmembrane segments, and an
extracellular loop that partially dips into the pore acting as a K+ selectivity filter.
There is also a very short, highly conserved length of polypeptide that allows for
the movement of the voltage-sensor by pulling open the pore during depolarization,
and pushing it closed at rest (Cooper, 2012). Humans have 36 6TM Kv channel
subunit genes that vary in their biophysical properties (Coetzee et al., 1999;
Cooper, 2012).
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Figure 1.2 Schematic of Kv4 ion channel
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Kv4 channels are one subfamily of the voltage-gated K+ channels that are
in both the cortex and the NTS. There are 3 different Kv4 subtypes: Kv4.1, Kv4.2,
and Kv4.3 (Birnbaum et al., 2004). These channels influence neuronal firing
properties and cellular excitability (Jerng et al., 2004; Covarrubias et al., 2008;
Strube et al., 2015). Various K+ channel subunits have been found to modulate
Kv4 activity. The most well-characterized of those subunits are known as K+
channel interacting proteins (KChIPs). KChIPs are neuronal calcium sensors that
have a variable amino acid terminal domain and a conserved carboxyl terminal
with calcium binding motifs (Birnbaum et al., 2004). There are 4 different types of
KChIPs (KChIP1, KChIP2, KChIP3, KChIP4) that are found in the brain and
colocalize with the Kv4 family of channels (Birnbaum et al., 2004; Jerng et al.,
2004). KChIP1-4 have been shown to colocalize with all members of the Kv4 family
in a nonspecific manner (An et al., 2000; Bahring et al., 2001; Birnbaum et al.,
2004; Covarrubias et al., 2008; Cheng et al., 2016). When co-expressed with Kv4
channels, KChIPs increase current density by increasing the surface expression
Kv4 channels (Birnbaum et al., 2004; Jerng et al., 2004; Covarrubias et al., 2008;
Schwenk et al., 2008). Additionally, KChIPs can alter the kinetics of activation and
inactivation of Kv4 channels, such as hyperpolarizing the activation curve, quicken
recovery from inactivation, and slowing the rate of inactivation (Birnbaum et al.,
2004; Covarrubias et al., 2008). KChIPs can also promote channel trafficking to
the membrane (An et al., 2000; Jerng et al., 2004; Covarrubias et al., 2008).
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1.8.2 Association with TLE
While there are many Kv subtypes that have been associated with epilepsy
in humans and animals, this dissertation places particular focus on the Kv4
subfamily (D'Adamo et al., 2013; Villa and Combi, 2016). The Kv4 subfamily has
been shown to be associated with human epilepsies and it is also expressed in the
vagal complex (Singh et al., 2006; Smets et al., 2015; Villa and Combi, 2016).
Voltage-gated K+ (Kv) channels have been shown to be altered in individuals with
epilepsy with TLE (Singh et al., 2006; Villa and Combi, 2016). Kv channels play a
major role in neuronal excitability and K+ channelopathies can contribute to
seizures (Brenner and Wilcox, 2012; D'Adamo et al., 2013; Villa and Combi, 2016).
A truncated Kv4.2 subunit has been found to cause seizures in a patient case study
(Singh et al., 2006) and other gain of function mutations in Kv4.2 were found in
intractable epilepsy (Smets et al., 2015).
Kv4 channels are essential for the regulation of neuronal excitability,
specifically modulating the A-type current (IA). The modulation of IA is crucial in the
repolarization phase of the action potential and prevents action potential back
propagation. Bernard et al. has shown hippocampal neurons from pilo-SE mice
have decreased Kv4.2 subunit expression and altered IA (Bernard et al., 2004).
However, in this study, there was no mention of how long the mice had
spontaneous seizures prior to being used in their experiments. This is crucial as
many rodents develop spontaneous seizures at different time points (Shibley and
Smith, 2002), which may have an effect on Kv4.2 expression. A separate study
found a decrease in Kv4.2 and KChIP2 expression in the hippocampus 4 and 12
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weeks after pilo-SE treatment (Monaghan et al., 2008). Another study measured
Kv4.2 expression in the chronic spontaneous seizure phase and found that there
was a decrease in Kv4.2 and KChIP1 protein levels in the hippocampus (Su et al.,
2008). Alterations in these channels have yet to be investigated in brain regions
outside of the hippocampus in a mouse model of TLE.
Kv4 subtypes and IA have been shown to be expressed in the NTS and be
altered in pathological states. IA modulates synaptic transmission to other vagal
complex pathways, current amplitude, activation kinetics, and protects against
excitotoxicity (Bailey et al., 2002; Yang et al., 2005; Bailey et al., 2007; Covarrubias
et al., 2008; Strube et al., 2015). In pathological states, IA has been shown to be
altered in hypertension (Sundaram et al., 1997; Belugin and Mifflin, 2005).
Additionally, pharmacologic blockade of IA modulates electrophysiological
properties of NTS neurons and attenuates baroreflex regulation of heart rate
(Butcher and Paton, 1998). Therefore, if the NTS altered during TLE, IA may also
have altered function as well.
1.9

Study Aims and Significance
This study will focus on the association between the pilo-SE induced model

of TLE, central control of autonomic function, and SUDEP. This study will further
focus on alterations in GABA NTS neuron function during epileptogenesis. Other
studies examined cardiac function acutely following pilocarpine; therefore, this
study will have longer time points allowing for the investigation of long-term effects
of epilepsy development with chronic spontaneous seizures on cardiac and GABA
NTS function. The investigation into mechanisms of SUDEP in TLE could lead to
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the development of SUDEP biomarkers or preventative treatments in an underresearched population that is at high risk for SUDEP. The hypothesis that the
pilocarpine-induced SE model of TLE is associated with SUDEP, altered cardiac,
and alterations in the synaptic and functional properties of GABAergic NTS
neurons was tested.
The specific aims of this project are as follows:
1) Determine if pilo-SE mice suffer from SUDEP with related changes in
cardiac and GABA NTS neuron function.

Because the pilocarpine-

induced SE model of TLE has not been used to study SUDEP, it was first
determined if pilo-SE mice die suddenly in the weeks following survival from
the initial pilocarpine-induced SE. Cardiac and autonomic dysfunction
occurs in individuals with TLE, thus ECG was used to investigate these
factors in the weeks following pilocarpine-induced SE. Lastly, as GABAergic
NTS neurons directly modulate autonomic output to the periphery,
electrophysiology was used to assess their function 1, 6, and 12 weeks after
pilocarpine-induced SE.
2) Determine if Kv4 subunits and IA are altered in the pilo-SE model of
TLE in GABA NTS neurons. Immunohistochemistry and western blot have
shown that Kv4 subunits are downregulated in the hippocampus following
pilocarpine-induced SE. No studies have assessed alterations in Kv4
expression or IA in the context of TLE within vagal complex. Whole-cell
patch-clamp electrophysiology was used to measure action potential
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frequency and half-width, and to isolate IA density. Differential expression
of Kv4.1, Kv4.2, Kv4.3 and KChIPs1,3, and 4 was also measured.
3) Utilize chemogenetic manipulation of GABA NTS neurons to
determine if activation of these neurons can alter seizure threshold.
Designer receptors exclusively activated by designer drugs (DREADDs)
have been shown to selectively excite or inhibit specific neuronal subtypes
in order to modulate both animal behavior and neuronal function. The
excitatory DREADD, pAAV8-hSyn-DIO-hM3D(Gq)-mCherry, was used to
selectively excite GABAergic NTS neurons in pilo-SE mice. In vivo studies
were done to determine if behavioral seizures could be elicited via DREADD
activation or if seizure latency could be modulated. Electrophysiology was
used to determine the effect of DREADD activation on firing properties of
GABA NTS neurons and synaptic properties of local DMV neurons.
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Chapter 2 Materials and Methods
2.1

Mice
For the survival study and in vivo electrocardiography (ECG) in Chapter 3,

5

week old male

CD-1 mice (Harlan Laboratories were used). For

electrophysiology studies in Chapters 3 and 4, 4-6 week old male Green Inhibitory
Neuron (i.e. GIN; FVB-Tg (GADGFP) 4570Swn/J; The Jackson Laboratory) was
used. GIN mice utilize GFP as a fluorescent reporter for somatostatin expressing
GABAergic neurons within the NTS, which allows for the targeted recording of
these neurons (Oliva A.A. et al., 2000). For chemogenetic studies in Chapter 5, 46 week old male Slc32a1tm2(cre)Lowl/J (i.e. Vgat-ires-cre; The Jackson Laboratory)
were used. Vgat-ires-cre mice express cre recombinase activity in GABAergic
neurons without interrupting endogenous vesicular GABA transport activity. All
procedures were approved by the University of Kentucky Animal Care and Use
Committee and NIH guidelines were adhered to for the care and use of animals.
All animals were housed in Association for Assessment and Accreditation of
Laboratory Animal Care approved facilities, on a 14:10 light:dark cycle with food
and water available ad libitum.
2.2

The Pilocarpine-Induced Model of TLE
TLE was induced in all experimental mice following procedures similar to

that of Shibley and Smith 2002 (Shibley and Smith, 2002). First, all mice were
given an intraperitoneal (i.p.) injection of methylscopolamine (1 mg/kg in 0.9%
saline). Methylscopolamine is a muscarinic antagonist that does not cross the
blood brain barrier and its administration serves to reduce the peripheral

38

convulsant effects of pilocarpine. After 20 minutes, mice were given either an i.p.
injection of pilocarpine (280-285 mg/kg in 0.9% saline) or vehicle (0.9% saline).
Pilocarpine is a tertiary amine that readily crosses the blood brain barrier and acts
as a nonselective muscarinic receptor agonist (Geller, 1984). Twenty to 30 minutes
after pilocarpine injection, mice began to display behavioral seizures which are
rated on based on a modified Racine scale, from category 1-5, with 5 being the
most severe (Racine, 1972). All mice were monitored for behavioral seizures for 2
hours post-injection. Category 1 and 2 consist of tail-stiffening, freezing, wet dog
shakes, and facial automatisms. All mice exhibited some or all of these behaviors.
Category 3 (i.e. unilateral forelimb myoclonus), category 4 (i.e. bilateral forelimb
myoclonus and rearing), and category 5 (i.e. bilateral fore- and hindlimb myoclonus
and transient loss of postural control) were considered to be generalized
convulsive seizures. Seizures were typically 30-90 seconds in duration and
separated by periods of relative inactivity. Mice that displayed a minimum of 3
category 3-5 seizures were considered to have undergone status epilepticus (SE)
and were subsequently classified as pilo-SE mice. Greater than 90% of pilo-SE
mice went on to develop spontaneous seizure activity 4-6 weeks post-injection
(Shibley and Smith, 2002; Winokur et al., 2004; Bhaskaran and Smith, 2010b). No
seizure activity was observed in control mice at any time post-injection.
In addition to standard diet, mice were given water-moistened food and a
5% glucose solution in their cage for 4 days post-treatment. Animals were also
given diet gel to supplement their standard chow and aid in avoiding dehydration.
Animals were weighed twice a day for 4 days following SE. If an animals weight
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decreased by more than 20% following SE and they did not recuperate following
subcutaneous ringer solution injections, they were euthanized.
A small cohort of GIN mice were observed two weeks prior to their use in
electrophysiology experiments for behavioral seizure activity. Mice were observed
for 2 hours, 3 times per week (Shibley and Smith, 2002; Winokur et al., 2004; Hunt
et al., 2013). Using this same protocol, behavioral observation for seizures were
conducted in a small cohort of Vgat-ires-cre animals in order to establish that they
developed chronic spontaneous seizures, as some mouse strains are resistant to
seizure morphology (Schauwecker, 2012).
2.3

Brainstem Slice Preparation
Patch-clamp recordings were made in brainstem slices from mice. Mice

were deeply anesthetized via inhalation of isofluorane to effect (i.e. lack of
response to toe-pinch) and decapitated. The brain was removed and placed into
ice-cold (2-4 C) artificial cerebrospinal fluid (ACSF) containing (in mM): 124 NaCl,
3 KCl, 2 CaCl2, 1.3 MgCl2, 1.4 NaH2PO4, 26 NaHCO3, and 11 glucose (pH 7.27.4). The brain was blocked on an ice-cold stand and glued on a platform for
sectioning in the coronal plane. Transverse 300 m thick sections from the caudal
brainstem were made in cold ACSF using a vibrating microtome (Vibratome series
1000; Technical Products International) and transferred to a holding chamber
containing warmed (30-32C) oxygenated ACSF. Slices were incubated for at least
one hour in the holding chamber prior to use in electrophysiological experiments.
These brainstem slices contain the NTS and DMV and preserve primary afferent
connections in the solitary tract.
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2.4

Electrophysiological Recordings
Brainstem slices were transferred to a chamber mounted on a fixed stage

under an upright microscope (BX51WI; Olympus, Center Valley, PA), where it was
superfused with continuously warmed (30-32C) oxygenated ACSF. Somatostatin
containing GABAergic EGFP neurons were targeted under epifluorescence. Patch
pipettes for recordings were pulled from borosilicate glass (open tip resistance 35 M; King Precision Glass Co, Claremont, CA). The pipette solution contained
(in mM): 130 K+ gluconate, 1 NaCl, 5 EGTA, 10 HEPES, 1 MgCl2, 1 CaCl2, 3 KOH,
and 2 ATP. Recordings were obtained using an Axon 700B amplifier (Molecular
Devices, San Jose, CA), low pass filtered at 2-3 kHz, digitized at 20 kHz, and
recorded onto a computer (Digidata 1440A, Molecular Devices). Seal resistance
was between 2 and 5 G for on-cell and whole-cell recordings.
On-cell patch-clamp recordings of spontaneous action potentials were
recorded in voltage clamp mode at resting membrane potential in GABAergic NTS
neurons. For whole-cell patch-clamp recordings, cells were voltage-clamped at
-70 mV and allowed to equilibrate with the pipette recording solution for
approximately five minutes. Spontaneous and miniature excitatory postsynaptic
currents (sEPSCs and mEPSCs) were recorded in voltage-clamp mode at a
holding potential of -70 mV. Resting membrane potential was recorded in I=0
mode, where no holding current was applied. Occasionally, spontaneous firing
activity was seen in I=0, in which case the resting membrane potential was
calculated by averaging regions where there was not firing activity. Spontaneous
action potentials and current-voltage (I-V) curves were recorded in current-clamp
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mode at resting membrane potential (i.e. I=0 pA). I-V curves were completed to
measure GABAergic NTS neuron input resistance (Rin) and consisted of 6 current
injections (-20 pA to +30 pA, 10 pA increments, 500 ms duration) with the resulting
change in membrane potential being measured. Rin was calculated by plotting the
linear portion of the I-V curve and calculating the slope. Series resistance was less
than 25 M and monitored periodically throughout the recordings. If the series
resistance changed by more than 20% over the course of the experiment, the
recording was discarded.
2.5

Drugs Used for Electrophysiological Recordings
The drugs and their respective concentrations used for experiments were:

Tetrodotoxin (TTX; 1 M; Alomone Labs), 4-Aminopyridine (4-AP; 5 mM; SigmaAldrich), (-)-Bicuculline Methiodide (BIC; 30 M; Tocris Biosciences), Kynurenic
Acid (KYN; 1 mM; Sigma-Aldrich); Tetraethylammonium Chloride (TEA-Cl; 10 mM;
Sigma-Aldrich).
2.6

Statistical Analyses
For the survival study, a Kaplan-Meier survival curve was generated to

assess mortality differences between control and pilo-SE mice. A log-rank (MantelCox) test was used to assess statistical significance. This is a nonparametric test
used to compare the survival of two samples. Data analysis was performed using
GraphPad Prism (La Jolla, CA).
Electrophysiology measurements included sEPSC frequency, sEPSC
amplitude, mEPSC frequency, mEPSC amplitude, spontaneous action potential
frequency (on-cell and whole-cell), paired-pulse ratio (PPr), frequency dependent
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depression, spontaneous action potential half-width, A-type K+ current amplitude,
sIPSC frequency, sIPSC amplitude, resting membrane potential and Rin. Analysis
of electrophysiology measurements was performed using pClamp 10.2,
MiniAnalysis (version 6.0.7, Synaptosoft; Decatur, GA) and GraphPad (La Jolla,
CA) software programs. To measure sEPSC, mEPSC, whole and on-cell
spontaneous action potential firing frequencies a 2-minute segment of continuous
firing activity was used. For sEPSCs and mEPSCs only events with five times the
root mean squared baseline noise were included. Events characterized by a fast
rise phase and exponential decay were automatically detected and then manually
verified by MiniAnalysis. An unpaired t-test was used to compare on and wholecell action potential frequency, sEPSC frequency, sEPSC amplitude, mEPSC
frequency, mEPSC amplitude, PPr, frequency dependent depression, and action
potential half-width between control and pilo-SE mice. A two-way ANOVA with a
Sidak’s post hoc was used to compare the peak transient outward K + current at
each voltage step between control and pilo-SE mice in normal ACSF and before
and after the application of 4-AP. A 2-way ANOVA (Tukey’s post hoc) was done to
test for differences in the voltage dependence of activation and inactivation
between control and pilo-SE mice. A 2-way ANOVA (Tukey’s post hoc) was
completed to assess differences in steady state values between control and piloSE mice. All data are presented as mean  SEM and statistical significance was
set at p < 0.05.
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Chapter 3 Functional neuroplasticity in the nucleus tractus solitarius and
increased risk of sudden unexpected death in mice with acquired temporal
lobe epilepsy
This chapter was published in eNeuro, Sept/Oct. 2017; 4(5). Brian P. Delisle and
Bret N. Smith are additional authors for this paper and this chapter is similar to the
published manuscript.
3.1

Introduction
Sudden unexpected death in epilepsy (SUDEP) occurs when an individual

with epilepsy who is otherwise healthy dies suddenly for unknown reasons
(Annegers, 1997; Nashef, 1997; Nashef et al., 2012; Tolstykh and Cavazos, 2013).
For epilepsy patients, the risk of sudden unexpected death is >20-fold higher than
in the general population and accounts for ~17% of epilepsy-related deaths
(Nashef, 1997; Kalume et al., 2013; Tolstykh and Cavazos, 2013), so it is
imperative to elucidate its underlying mechanisms. Patients with longstanding
epilepsy characterized by frequent generalized tonic-clonic seizures that are
relatively poorly controlled are at highest risk (Tolstykh and Cavazos, 2013;
Thurman et al., 2014). Patients with TLE represent ~60% of all epilepsies, and
seizures are medically intractable in about 30% of these patients, making this the
largest population at risk of SUDEP, yet mechanisms underlying increased SUDEP
risk have not been identified in animal models of acquired TLE. Peri-ictal, centrally
originating or peripheral autonomic irregularities leading to cardiorespiratory
collapse may be the immediate cause of death in SUDEP (Ryvlin et al., 2013), but
few studies have been aimed at identifying mechanisms of autonomic failure.
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Seizures can increase activity of neurons in brainstem autonomic areas,
independently of physical activity or peripheral metabolic influences (Kanter et al.,
1995; Takakura et al., 2011) and autonomic irregularities often develop over time
in individuals with epilepsy, implicating central or peripheral autonomic reactive
neuroplasticity as a potential driver of increased SUDEP risk in patients and rodent
epilepsy models (Glasscock et al., 2010; Massey et al., 2014; Biet et al., 2015).
Thus, recurrent seizures might induce changes in central or system physiologic
functions that increase the risk for sudden death.
The brainstem vagal complex is the principal neural center mediating
parasympathetic visceral regulation. Within the vagal complex, neurons of the
nucleus tractus solitarius (NTS) receive viscerosensory information via vagal
afferents and project their axons to preganglionic parasympathetic motor neurons
in the dorsal motor nucleus of the vagus (DMV) and the nucleus ambiguus (NA;
(Andresen and Kunze, 1994; Doyle and Andresen, 2001; Wang et al., 2001a;
Wang et al., 2001b; Davis et al., 2004; Travagli et al., 2006; Glatzer et al., 2007;
Bailey et al., 2008) as well as to brainstem and hypothalamic areas responsible for
premotor sympathetic regulation and respiratory reflexes (Takenaka et al., 1995;
Fontes et al., 2001; Irnaten et al., 2001; Bonham et al., 2006; Affleck et al., 2012;
Zoccal et al., 2014). Inhibitory GABAergic NTS neurons participate in vagal
reflexes and prominently regulate parasympathetic output (Davis et al., 2004;
Travagli et al., 2006). Evidence from genetic epilepsy models suggests that
epilepsy-related alterations in peripheral or central vagal function contribute to
cardiorespiratory collapse and SUDEP (Glasscock et al., 2010; Cheah et al., 2012;
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Glasscock et al., 2012; Kalume et al., 2013; Aiba and Noebels, 2015). Central
vagal circuit plasticity is prominent in disease states that affect autonomic
homeostasis (Mei et al., 2003; Bach et al., 2015; Bhagat et al., 2015; Boychuk et
al., 2015a) and seizure-related derangement of central vagal system function has
been briefly described, manifesting as increased likelihood of spreading
depolarization in the NTS (Aiba and Noebels, 2015). Reactive neuroplasticity in
the central vagal complex, however, has not been investigated in animals with
acquired TLE.
We used the pilocarpine-induced status epilepticus (pilo-SE) model of TLE
in mice (Shibley and Smith, 2002; Borges et al., 2003; Winokur et al., 2004;
Groticke et al., 2007; Bhaskaran and Smith, 2010a; Bhaskaran and Smith, 2010b;
Hunt et al., 2013) to identify long-term changes in NTS neuron function coinciding
with the development of TLE. Because the NTS is the primary integration center
for cardiorespiratory reflexes, and GABA neurons in particular are principal
participants in vagal reflex activity (Glatzer et al., 2007; Bailey et al., 2008)
increased excitability of these neurons would be consistent with an increased
propensity for central autonomic failure that could lead to SUDEP in TLE. We
tested the hypothesis that reactive plasticity of GABAergic circuitry in the NTS
emerges over time in mice that survive pilocarpine-induced SE.
3.2

Methods
3.2.1 ECG Telemetry
Mice were anesthetized with 2.5% isofluorane in 100% O2 at 1.5 L/min and

2-inch midline incision was made through the skin of the abdomen exposing the
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fascia. Hemostats were used to separate the fascia from the skin and create space
for the ECG leads underneath the skin. The telemeter body (model ETA-F10; Data
Sciences International, St.Paul, MN) was implanted on the right flank with the
positive lead near the right pectoral muscle and the negative lead on the left side
of the abdomen. The leads were secured by being embedded in the fascia
underneath the skin. The incision was closed with staples (autoclips, Kent
Scientific Corporation, Torrington, CT) and allowed to heal for two weeks prior to
use.
Telemeters were turned on at least 24 hours prior to recordings in order to
minimize disturbances and stress to the mice. Data were recorded for 24 hours
pre-injection of vehicle or pilocarpine, 24 hours after injection and at 6 and 12
weeks after injection. ECG data were collected with DSI DataQuest A.R.T. 4.31
and Ponemah 6.10 and analyzed with Ponemah 6.10 telemetry software. Data
were acquired at a sampling rate of 1000 Hz, which is the standard rate used for
mice and results in a smooth physiologic signal when the ECG waveforms are
graphed; the telemetry device used a factory preset sampling rate of 200 Hz. No
low-pass or high-pass filtering was applied during data acquisition. For ECG
waveform analysis, the software was set to use a 40% QRS detection threshold
(percentage of the largest derivative peak in QRS segment resulting in an R that
satisfies the minimum heart rate criteria), a minimum of R deflection of 0.25 mV, a
maximum heart rate of 1000 bpm, and a minimum heart rate of 80 bpm.
Average heart rate was calculated from data from 1 hour recording periods,
as described previously (Metcalf et al., 2009a; Ho et al., 2011; Schroder et al.,
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2015); all recordings were performed during seizure-free periods. The RR interval
was manually examined and filtered for abnormal beats by sorting the RR interval
from shortest to longest and deleting cycles that were two standard deviations from
the average RR interval, and the ECG channel was subsequently reanalyzed by
setting upper and lower limits on RR values (Thireau et al., 2008). Areas of the
recording that contained skipped beats or loss of signal were also deleted. The
remaining cycles were then averaged to comprise the NN (i.e. RR) interval, which
was then used to calculate the standard deviation of the N-to-N interval (SDNN)
and the root mean squared of the standard deviation of the RR interval (RMSSD).
The SDNN was calculated by taking the square root of the averaged NN interval.
The RMSSD was calculated with the following steps: (1) the difference between
the NN interval and delayed NN interval was squared; (2) the squared difference
was summed; (3) the number of NN intervals was counted; and (4) the sum of the
difference squared was divided by the count of NN intervals. RMSSD is reported
as the square root of this value.
3.2.2 Electrophysiological Stimulation
Electrical stimulation was performed using a platinum-iridium concentric
bipolar electrode (125 m diameter, FHC, Bowdoinham, ME) that was placed in
the solitary tract (ST) (Glatzer and Smith, 2005; Glatzer et al., 2007). Sets of 5
current pulses (30-50 A; 400 s) were delivered at interpulse intervals of 30 ms
at 50 Hz to the ST and responses in NTS neurons voltage-clamped at -70 mV were
recorded and the constant latency and amplitude evoked EPSC (eEPSC)
responses were measured. The stimulus intensity was adjusted so that eEPSCs
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occurred > 80% of the time in GABAergic NTS neurons when stimulation was
applied to the ST. Thirty stimulation sweeps were applied to each cell and
averaged for further assessment. The ratio of the second to the first eEPSC (i.e.
paired-pulse ratio, PPr) was measured in order to infer changes in the probability
of excitatory neurotransmitter release. An increase in the release ratio typically
correlates with a decrease in the probability of presynaptic neurotransmitter
release, in this case presynaptic input arising from the ST (Schild et al., 1995;
Zucker and Regehr, 2002; Pamidimukkala and Hay, 2004; Chen and Bonham,
2005; Glatzer and Smith, 2005; Glatzer et al., 2007; Laaris and Weinreich, 2007).
Frequency-dependent depression (FFD) is a common characteristic of secondorder NTS neurons that receive input from the ST (Miles, 1986; Doyle and
Andresen, 2001; Bailey et al., 2008; Kline, 2008). In order to assess the FDD, the
ratio of the amplitudes of the 5th eEPSC to the 1st eEPSC are measured. Stimulus
sweeps were only included if an eEPSC was elicited after each stimulation in that
sweep and the constant latency was less than 0.2 ms to ensure that responses to
stimulation were monosynaptic in nature (Glatzer et al., 2007; Bailey et al., 2008).
Methods for Chapter 3 also included: methylscopolamine and pilocarpine
injections,

seizure

assessment,

and

on-

and

whole-cell

patch-clamp

electrophysiology as described in Chapter 2 of this dissertation.
3.3

Results
3.3.1 Pilocarpine-induced SE as a model of SUDEP
Spontaneous seizure activity was monitored in a cohort of mice (n=6 control

mice; n=6 pilo-SE mice) for 1 week between 11 and 12 weeks post-SE. Similar to
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previous reports (Shibley and Smith, 2002; Winokur et al., 2004; Hunt et al., 2013)
spontaneous seizures were observed during this period in 83% (5 of 6) pilocarpinetreated mice that survived SE. A separate cohort of mice were monitored for longterm survival after pilocarpine-induced SE. Similar to previous reports (Shibley and
Smith, 2002; Winokur et al., 2004), all vehicle-injected mice survived the duration
of the monitoring period of 150 days (100%; n=10 mice). Between 1 and 7 days
after pilocarpine-induced SE, there was a 13.33% mortality rate (2/15 mice). These
mice were not considered to have died of SUDEP, as epilepsy (i.e. with
spontaneous seizures) likely had not developed by this time. Of the 13 pilocarpinetreated mice that survived for greater than 7 days post-SE, only 3 mice (23%)
survived to 150 days post-treatment, with no obvious trauma or other incident; 60%
died after greater than 40 days post-SE (Fig. 3.1). Thus, the survival rate of mice
that survived pilo-SE was significantly decreased at 150 days compared to with
vehicle-treated control mice (log-rank Mantel-Cox; p = 0.0002).
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Figure 3.1 Pilocarpine-induced SE (pilo-SE) increases the risk of sudden death.
Pilocarpine-treated mice (Pilo-SE; n=15) have a decreased survival rate (23%)
compared to control mice (n=10, 100%; Log-rank Mantel-Cox; p = 0.0002). Mice
that survived SE died suddenly and unexpectedly at post-SE time points
associated with the development of spontaneous seizures.
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3.3.2 Increased action potential firing in GABAergic NTS neurons from
pilo-SE mice is glutamate receptor dependent
Seizure-induced depolarization in the NTS of mice with genetic epilepsies
originates in the lateral NTS (Aiba and Noebels, 2015), and area densely
comprised of GABAergic neurons (Blessing, 1990; Fong et al., 2005; Glatzer et
al., 2007). We hypothesized that GABAergic NTS neurons, most of which receive
primary viscerosensory input from the vagus nerve (Glatzer et al., 2007; Bailey et
al., 2008), are altered functionally post-SE. On-cell recordings of GABAergic NTS
neurons were performed to determine whether spontaneous action potential firing
differed between control and pilo-SE mice (Fig. 3.2A,B,E). One week posttreatment, GABAergic NTS neurons from seven pilo-SE mice displayed
significantly higher action potential firing frequency (3.35 ± 0.46 Hz; n=20 cells)
compared with NTS GABAergic neurons from seven age-matched control mice
(1.32 ± 0.30 Hz; n=15 cells; p = 0.002). Spontaneous action potential firing in
GABAergic NTS neurons was also significantly increased 6 weeks after treatment
in five pilo-SE mice (3.32 ± 0.65 Hz; n=16 cells) compared with eight age-matched
control mice (2.10 ± 0.25 Hz; n=26 cells; p = 0.046). Similarly, action potential firing
frequency remained significantly greater in GABAergic NTS neurons from seven
age-matched pilo-SE (4.27 ± 0.96 Hz; n=24 cells) than seven age-matched control
mice (2.21 ± 0.27 Hz, n=23 cells; p = 0.0048) 12 weeks post-treatment (Fig.3.2E).
Therefore, action potential frequency was consistently higher in GABAergic NTS
neurons in mice that survived SE than in control mice.

52

To determine whether the increase in firing frequency was due to increased
activation of ionotropic glutamate receptors, spontaneous action potential firing
was recorded in the presence of the ionotropic glutamate receptor antagonist,
kynurenic acid (KYN; 1mM; Fig.3.2C,D,F). In the presence of KYN, the action
potential firing frequency in GABAergic NTS neurons from pilo-SE mice was similar
to that of control mice 1, 6, and 12 weeks post-treatment (week 1: p = 0.47; week
6: p = 0.83; week 12: p = 0.78; Fig.3.2F). Therefore, increased action potential
firing in GABAergic NTS neurons from mice that survived SE depended on
activation of ionotropic glutamate receptors, implicating increased glutamatemediated, excitatory synaptic drive to these neurons during epileptogenesis.
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Figure 3.2 Action potential frequency in GABAergic nucleus tractus solitarius
(NTS) neurons from pilo-SE mice is dependent on glutamate receptor activation.
A) Representative traces showing action potential firing (Na + currents) in
GABAergic NTS neurons in slices from control mice recorded in normal ACSF
(nACSF) at three different time points (i.e., 1, 6, and 12 weeks) after vehicle
treatment. (B) Representative traces showing action potential firing in GABAergic
NTS neurons from mice that survived pilo-SE under normal recording conditions
(nACSF) at three different time points after SE. (C) Representative traces of action
potential firing in control mice in the presence of kynurenic acid (KYN; 1mM) at
these same time points. (D) Representative traces of action potential firing in the
presence of KYN in pilo-SE mice. (E) Action potential firing frequency is
significantly greater in pilo-SE mice compared to age-matched control mice at 1,
6, and 12 weeks post-treatment (unpaired t-test; *denotes significance at p<0.05).
(F) In the presence of KYN, action potential firing frequency in NTS GABA neurons
from pilo-SE mice was not significantly different than in control mice (unpaired ttest; p>0.05).
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3.3.3 GABAergic NTS neurons display increased excitatory regulation
An increase in spontaneous action potential firing in GABAergic NTS
neurons from pilo-SE mice could occur because of altered intrinsic and/or synaptic
properties. To determine whether intrinsic properties were altered post-SE, we
measured the resting membrane potential and input resistance in GABAergic NTS
neurons and found that there were no significant differences between control and
pilo-SE mice at any time point (Table 3.1). Because firing rate differences were
abrogated by KYN, we hypothesized that excitatory glutamatergic synaptic input
was increased after pilo-SE. To test this hypothesis, whole-cell patch-clamp
recordings were used to examine the frequency and amplitude of spontaneous and
miniature EPSCs in GABAergic NTS neurons from age-matched control and piloSE mice (Fig 3.3). One week post-treatment, sEPSC frequency in GABAergic NTS
neurons from six pilo-SE mice (4.98 ± 0.98 Hz; 12 cells) was significantly greater
than seven control mice (1.61 ± 0.40 Hz; n=10 cells; p = 0.007). The increased
sEPSC frequency was also seen at 6 weeks post-SE (five control mice: 2.17 ±
0.46 Hz; n=9 cells; seven pilo-SE mice: 3.40 ± 0.36 Hz; n=13 cells; p = 0.045) and
12 weeks post-treatment in seven pilo-SE mice (2.57 ± 0.46 Hz; n=15 cells)
compared with 11 age-matched control mice (1.55 ± 0.27 Hz; n=20 cells; p = 0.03;
Fig3.3C). There was no significant difference in sEPSC amplitude at any time point
post-treatment (week 1: p = 0.82; week 6: p = 0.89; week 12: p = 0.20; Fig3.3D).
Therefore, glutamate release onto NTS GABAergic neurons was increased after
pilo-SE, and this increased release period persisted for at least 3 months post-SE.
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Table 3.1 Resting Membrane Potential and Input Resistance.
Resting membrane potential (RMP) and input resistance of GABAergic NTS
neurons in mice that survived SE is not significantly different from age-matched
control mice at any time point (unpaired t-test; p > 0.05).

Week 1
Week 6
Week 12

Input Resistance (MΩ)
Control
Pilo-SE

Resting
(mV)
Control

1160 ± 600
1369 ± 346
2477 ± 611

-47.65 ± 5.35
-52.23 ± 3.69
-55.93 ± 3.31

1590 ± 490
1180 ± 293
1905 ± 429

Membrane

Potential

Pilo-SE
-51.69 ± 4.25
-53.32 ± 3.63
-57.57 ± 3.33
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Figure 3.3 Significantly increased sEPSC frequency in GABAergic NTS neurons
from pilo-SE mice.
(A) Representative traces showing sEPSCs in a GABAergic NTS neuron from
control mice 1, 6, and 12 weeks post-treatment. (B) Representative traces showing
sEPSCs in a GABAergic NTS neuron from pilo-SE mice 1, 6, and 12 weeks posttreatment. (C) sEPSC frequency is significantly higher in GABAergic NTS neurons
from pilo-SE mice compared to control mice 1, 6, and 12 weeks post-treatment
(unpaired t-test; *denotes significance). (D) sEPSC amplitude is not significantly
different (unpaired t-test; p>0.05) between control and pilo-SE mice at any time
point.
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The hypothesis that the increased release of glutamate depended on action
potentials in afferent neurons within the slice was tested by measuring the
frequency and amplitude of mEPSCs in the presence of tetrodotoxin (TTX, 1 µM),
which was added to ACSF to block Na+ channels and prevent action potential firing
(Fig.3.4). Unlike for sEPSCs at 1 week post-treatment, mEPSC frequency was not
significantly increased in five pilo-SE mice (2.37 ± 0.35 Hz; n=9 cells) compared
with three control mice (1.88 ± 0.34 Hz; n=8 cells; p = 0.33). Miniature EPSC
frequency was significantly increased, however in GABAergic NTS neurons at 6
weeks (five control mice: 1.36 ± 0.24 Hz; n=15 cells; six pilo-SE mice: 3.10 ± 0.47
Hz; n=13 cells; p = 0.003) and 12 weeks (five control mice: 1.46 ± 0.13 Hz; n=15
cells; seven pilo-SE mice: 2.52 ± 0.38 Hz; n=12 cells; p = 0.007; Fig 3.4C).
Miniature EPSC amplitude in GABAergic NTS neurons from control and pilo-SE
mice was not significantly different at any time point post-treatment (week 1, p =
0.85; week 6, p = 0.18; week 12, p =.10; Fig 3.4D). Therefore, glutamate release
was increased in GABAergic NTS neurons after pilo-SE, and the increase detected
after 6 weeks did not depend on action potential firing in glutamatergic neurons
contained within the slice preparation, suggesting that changes at the level of the
synaptic terminals contributed to the development of altered glutamate release in
the NTS during epileptogenesis.
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Figure 3.4 Significantly increased mEPSC frequency in GABAergic NTS neurons
from pilo-SE mice.
(A) Representative traces showing mEPSCs in a GABAergic NTS neuron from a
control mouse 1, 6, and 12 weeks post-treatment. (B) Representative traces
showing mEPSCs in a GABAergic NTS neuron from a pilo-SE mouse 1, 6, and 12
weeks post-treatment. (C) mEPSC frequency is significantly higher in GABAergic
NTS neurons from pilo-SE mice compared to control mice at 6 and 12 weeks posttreatment (unpaired t-test; *denotes significance at p<0.05). (D) mEPSC amplitude
is not significantly different between control and pilo-SE mice at any time point
(unpaired t-test).
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3.3.4 Primary vagal afferent input to GABAergic NTS neurons was not
altered in pilo-SE mice
The increase in mEPSC frequency in GABAergic NTS neurons from piloSE mice suggests an increase in the probability of presynaptic glutamate release,
possibly including from vagal afferent terminals. Nerve terminals of viscerosensory
primary vagal afferents synapse directly onto second order sensory NTS neurons,
including GABAergic neurons, the majority of which receive primary vagal input
(Glatzer et al., 2007; Bailey et al., 2008). Synaptic responses evoked after
stimulating vagal afferents exhibit paired-pulse inhibition and frequency-dependent
depression (Miles, 1986; Doyle and Andresen, 2001; Glatzer and Smith, 2005;
Bailey et al., 2008). We therefore tested the hypothesis that glutamate release from
primary vagal afferents was enhanced in pilo-SE mice by measuring synaptic
responses to stimulation of the ST in GABAergic NTS neurons. Examples of
responses in NTS GABA neurons to repetitive stimulation of the ST in each group
are shown in Fig 3.5. One week post-treatment, the PPr was not significantly
different between three control mice (0.71 ± 0.07; n=8 cells) and three pilo-SE mice
(0.87 ± 0.10; n=8 cells; p = 0.27). At 6 weeks post-treatment, the PPr was not
significantly altered in four pilo-SE mice (1.02 ± 0.13; n=8 cells) compared with five
control mice (0.75 ± 0.14; n=5 cells; p = 0.16). There was also no significant
difference in the PPr at 12 weeks post-treatment between five control mice (0.71
± 0.06; n=11 cells) and six pilo-SE mice (0.82 ± 0.06; n=14 cells; p = 0.12; Fig
3.5D). Thus, the increased glutamate release in GABAergic NTS neurons that
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developed after pilo-SE was likely not due to modification of synaptic release
probability in vagal afferents.
Although changes in the PPr after SE survival are an indicator of alterations
in the releasable vesicle pool (Schild et al., 1995; Zucker and Regehr, 2002;
Pamidimukkala and Hay, 2004), frequency-dependent depression provides insight
into synaptic communication between the vagal afferent fibers and GABAergic
NTS neurons that may rely on additional mechanisms (Chen et al., 1999; Atwood
and Karunanithi, 2002; Kline, 2008; Zhao et al., 2015). Frequency-dependent
depression is a common characteristic of second-order NTS neurons receiving
viscerosensory afferent input and has been hypothesized to contribute to central
adaptation during cardiovascular and respiratory reflexes (Miles, 1986; Doyle and
Andresen, 2001; Kline et al., 2005; Glatzer et al., 2007; Bailey et al., 2008; Kline,
2008).
We also tested the hypothesis that frequency-dependent depression was
altered in mice that survived SE by analyzing the amplitude ratios of the 5 th to the
1st eEPSC in a train (Fig 3.5F). Similar to the PPr analysis, there was no significant
difference between three control mice 1 week (0.55 ± 0.09; n=8 cells) and three
pilo-SE mice (0.56 ± 0.08; n=8 cells; p = 0.89), 6 weeks (control: 0.52 ± 0.08; n-=5
cells; pilo-SE: 0.78 ± 0.12; n=8 cells; p = 0.14), or 12 weeks post-treatment (control:
0.56 ± 0.07; n=11 cells; pilo-SE: 0.71 ± 0.07; n=14 cells; p = 0.31; Fig3.5F). These
data are consistent with the hypothesis that release properties at vagal afferent
synapses with GABAergic NTS neurons are not altered after pilo-SE.
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Figure 3.5 Paired pulse ratio (PPr) and frequency dependent depression are
transiently altered in pilo-SE mice.
(A) Representative traces of eEPSC responses in GABAergic NTS neurons 1
week post-treatment from control and pilo-SE mice. (B) Representative traces of
eEPSC responses in GABAergic NTS neurons 6 weeks post-treatment from
control and pilo-SE mice. (C) Representative traces of eEPSC responses in
GABAergic NTS neurons 12 weeks post-treatment from control and pilo-SE mice.
(D) The PPr was not significantly different between control and pilo-SE mice at any
time point post-treatment (unpaired t-test; p>0.05). (E) The ratio of the 5th response
amplitude to that of the 1st response was also not significantly altered in pilo-SE
mice at any time point (unpaired t-test; p>0.05).
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3.3.5 Heart rate and heart rate variability in mice surviving SE is not
altered long-term
In chemoconvulsant-induced SE models of acquired TLE in rats, changes
in cardiac rhythmicity that may reflect plasticity of either central or peripheral vagal
regulatory function or cardiac remodeling are detected coincident with
epileptogenesis (Metcalf et al., 2009b; Bealer et al., 2010; Biet et al., 2015). We
examined mouse ECG activity for changes in heart rate and HRV over time to
assess whether ongoing cardiac rhythms were altered following SE. Table 3.2
describes heart rate and two measures of HRV in six control mice and eight
pilocarpine-treated mice that survived SE. Heart rate was significantly increased
in mice that survived SE compared with their heart rate 24 hours before treatment
(baseline, 525.8 ± 22.02 bpm; post-SE, 636.1 ± 39.12 bpm; n=8 mice; p = 0.018).
This was also true for the SDNN, a measure of HRV. The SDNN was significantly
decreased 24 hours post-SE (baseline, 10.77 ± 0.21 ms; post-treatment, 9.85 ±
0.34 ms; p= 0.038). No significant differences were detected at any other time
points after SE induction in these same mice, nor were any differences detected
over the 12-week recording period in the RMSSD (two-way ANOVA; F
(3,46)=0.135; p = 0.939, Table 3.2).
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Table 3.2 Heat rate and heart rate variability (HRV) in mice that survived SE.
Heart rate and the standard deviation of the N-to-N interval (SDNN) were
increased 24 hours after SE, but no differences were detected at other time points
(Heart Rate: Two-Way ANOVA, F(3,46) = 2.52, p = .069; SDNN: Two-Way
ANOVA, F (3,46) = 2.25, p = 0.094). The root mean squared of the standard
deviation (RMSSD) was not significantly different at any time point (Two-Way
ANOVA, F (3,46) = 0.135, p = 0.939).

Baseline
24 h
Week 6
Week 12

Control (n=6)
Heart Rate SDNN
(bpm)
(ms)
539.42 ±
10.60
14.23
0.13
534.66 ±
10.68
8.92
0.08
549.96 ±
10.48
12.93
0.13
530.54 ±
10.68
9.28
0.09

±
±
±
±

RMSSD
(ms)
2.96 ±
0.65
3.37 ±
0.51
3.21 ±
1.25
3.12 ±
0.66

Pilo-SE (n=8)
Heart Rate SDNN
RMSSD
(bpm)
(ms)
(ms)
525.8 ±
10.77 ± 3.22 ±
22.02
0.21
0.38
636.10 ± 9.85 ±
2.86 ±
39.12
0.34
0.59
556.90 ± 10.47 ± 3.32 ±
26.26
0.23
0.45
524.10 ± 10.75 ± 3.27 ±
18.19
0.19
0.62
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3.4

Discussion
The present study investigated survival rates and changes in GABAergic

NTS neuron function in mice that survived pilo-SE. Mice that died within 1 week of
SE were considered to have failed to recover from SE and therefore not to have
died of SUDEP, since they likely did not have epilepsy. Of the mice that survived
the first week after pilocarpine-induced SE, just 23% survived to 150 days postSE, whereas 100% of control mice survived the duration of the study. Patients with
longstanding epilepsy characterized by frequent generalized tonic-clonic seizures
that are relatively poorly controlled are at highest risk for SUDEP (Surges and
Sander, 2012; Tolstykh and Cavazos, 2013; Massey et al., 2014; Thurman et al.,
2014; Dlouhy et al., 2016). SUDEP risk in patient populations with relatively rare
genetic epilepsies such as Dravet’s syndrome, which accounts for about 3% of
patients with epilepsy, is high (Wu et al., 2015), and many studies have been aimed
at elucidating the causes of SUDEP in genetic epilepsies. Patients with TLE
represent ~60% of all epilepsies, however, and seizures are medically intractable
in about one-third of TLE patients, making this the largest epilepsy population at
risk of SUDEP. The pilocarpine-induced SE model in mice represents a consistent
and highly replicable TLE model in which mice develop spontaneous seizures
within a few weeks after recovery from SE (Shibley and Smith, 2002; Winokur et
al., 2004; Scorza et al., 2009; Bhaskaran and Smith, 2010b), promoting this mouse
as a reasonable model of SUDEP in TLE. Pilocarpine plasma and brain levels peak
in the minutes after injection and fall to almost zero by 2 hours post-injection; it is
therefore doubtful that the single exposure to pilocarpine itself is responsible for
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our findings, which were measured days to months after injection (Romermann et
al., 2015). Additionally, microinjection of muscarinic receptor agonists in the NTS
alters function for 4-6 minutes after application without sustained changes
(Sundaram et al., 1988). Thus, decreased survivability and increased NTS circuit
excitability likely develop coincident with epileptogenesis in this model, rather than
as a result of a brief exposure to the muscarinic agonist.
Sudden unexpected death has been documented in mouse models of
genetic epilepsy (Goldman et al., 2009; Glasscock et al., 2010; Cheah et al., 2012;
Aiba and Noebels, 2015) and unexpected death has been noted anecdotally in
models of acquired TLE. In murine Kv1.1-null and Dravet’s syndrome genetic
epilepsy models, mice begin having seizures by approximately the third week of
life, and most animals do not survive past day 90 (Cheah et al., 2012). These
models use genetically mediated ion channel derangement to induce epilepsy, and
the channelopathies themselves could increase the likelihood of sudden death.
They can also result in altered electrical properties of cardiomyocytes,
complicating interpretations of the contribution of the effects of seizures-versus the
channelopathy itself to death (Auerbach et al., 2013). Conversely, seizures in the
pilocarpine-SE model induce reactive neuroplasticity, including ion channel and
synaptic reorganization in cortical structures (Shibley and Smith, 2002; Su et al.,
2008; Metcalf et al., 2009b; Bealer et al., 2010; Guo et al., 2013), and the present
results indicate they also induce remodeling in brainstem neurons or circuits, which
could contribute to central autonomic dysregulation. After the initial post-SE period,
heart rate and HRV were not affected in this mouse model, but cardiac arrhythmias
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have been detected in rats with acquired epilepsy (Powell et al., 2014). An increase
in baseline heart rate that coincided with sympathovagal imbalance has been
described in rats 2 weeks after pilocarpine injection, before the development of
spontaneous seizures (Metcalf et al., 2009a; Bealer et al., 2010). Although similar
changes were not detected in the mouse model of TLE used here, further work is
necessary to

determine

whether seizure-related

peripheral changes in

cardiorespiratory function accompany epileptogenesis in mice, perhaps using
isolated hearts to limit the influence of central autonomic regulatory mechanisms
(Powell et al., 2014). Our results are consistent with the hypothesis that central
autonomic plasticity develops during epileptogenesis in mice, regardless of any
potential for cardiac remodeling. Given the critical importance of the vagal complex
in regulating cardiac and respiratory reflex function, the development of increased
excitability in the NTS during epileptogenesis could reasonably be predicted to
increase the propensity for SUDEP in pilocarpine-treated mice.
The vagal complex in the caudal brainstem controls autonomic output to the
thoracic and most abdominal viscera. Within the vagal complex, GABAergic
neurons in the NTS receive, filter, and integrate viscerosensory information
regarding cardiorespiratory function and modulate both vagal and sympathetic
tone. Neuroplasticity in the vagal complex occurs in a variety of diseases (Mei et
al., 2003; Zsombok and Smith, 2009; Bach et al., 2015) and these neurons also
displayed functional changes weeks to months after SE. GABAergic neurons
displayed significantly and chronically increased spontaneous action potential
firing after SE. Significant differences in the passive membrane properties of
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GABAergic NTs neurons in pilo-SE mice were not detected, but the increase in
excitability was accompanied by increased glutamate release, evidence by
significantly higher sEPSC and mEPSC frequency versus age-matched controls.
Notably, age-related increases in NTS neuron excitability have been documented
(Johnson and Felder, 1993), so all comparisons here were made between agematched groups. The increased activity was eliminated when ionotropic glutamate
receptors were blocked, providing further evidence that long-term changes in
synaptic function are associated with epileptogenesis in this model.
The increased glutamate release shortly after pilo-SE was action potential
dependent, suggesting an initial increase in excitability of local interneurons. Action
potential-independent release, however, was significantly increased by 6 weeks,
suggesting the development of altered presynaptic release properties or formation
of new synapses in the NTS during epileptogenesis. Most GABAergic NTS
neurons receive direct vagal input (Glatzer et al., 2007; Bailey et al., 2008)
evidenced by eEPSCs with constant response latency (i.e. synaptic jitter <0.2 ms)
after ST stimulation. Reduced expression of K+ channels in the vagus nerve of
Kv1.1-null mice with epilepsy has been reported (Goldman et al., 2009; Glasscock
et al., 2010; Glasscock et al., 2012), and seizure-induced K+ channel remodeling
in vagal or other afferents could contribute to the increase in glutamate release
onto the GABAergic NTS neurons in pilocarpine-treated mice. However, changes
in synaptic release properties of vagal afferent terminals were not detected. In
addition to synaptic vagal afferent input, these receive glutamatergic synapses
originating from local NTS neurons and from other brain areas (Nishimura and
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Oomura, 1987; Zhang et al., 1999; Glatzer et al., 2007), consistent with the
hypothesis that synaptic reorganization of central neurons contributes to the
increased glutamate release in the NTS during epileptogenesis.
The cellular mechanisms underlying the increased glutamate release and
enhanced excitability of NTS GABA neurons have yet to be elucidated, but the
increase in synaptic excitation is reminiscent of the synaptic rearrangement that
occurs in cortical inhibitory interneurons during epileptogenesis (Hunt et al., 2011;
Zhang et al., 2011) and is consistent with dysregulation of autonomic control of the
thoracic and abdominal viscera. Increased synaptic excitation of GABAergic NTS
neurons would be expected to inhibit parasympathetic motor output and suppress
autonomic reflex responses in pilo-SE mice. Because NTS neurons also project to
neurons that inhibit medullary synaptic circuits (Card et al., 2006), increased
activity might also chronically disinhibit sympathetic motor output. Respiratory
centers receiving input from NTS neurons with altered excitability may also be
affected (Stornetta and Guyenet, 1999).
The chronic increase in glutamate-mediated cellular excitability after SE
may also make GABAergic NTS neurons more susceptible to sodium channel
inactivation in the event of excessive depolarization, as can occur if seizures
spread to this brainstem area (Aiba and Noebels, 2015). Spreading depression
and depolarization block have been well studied in cortical neurons and implicated
in the pathophysiology of migraine and stroke (Dreier and Reiffurth, 2015; Dreier
et al., 2015). NTS neurons are normally resistant to spreading depression
(Somjen, 2001; Dreier and Reiffurth, 2015), but focal cortical seizures in mice with
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epilepsy induced spreading depolarization in the NTS under conditions of
metabolic deprivation, which was followed by cardiorespiratory collapse and
sudden death in genetic epilepsy models (Aiba and Noebels, 2015). Spreading
depression is typically initiated in the lateral NTS, an area of the nucleus that
receives inspiratory vagal afferent input from the lung (Donnelly et al., 1989) and
is enriched in GABAergic neurons (Blessing, 1990; Fong et al., 2005; Glatzer et
al., 2007). The elevated synaptic excitability in GABAergic NTS neurons in mice
that survived pilocarpine-induced SE is consistent with an increased propensity for
depolarization block and action potential inactivation in these neurons, which could
increase the likelihood that depolarization block and spreading depression could
evolve in the NTS (Haller et al., 2001; Larrosa et al., 2006; Sawant-Pokam et al.,
2017). Whereas cortical seizures that spread to the NTS can evoke spreading
depolarization associated with SUDEP, other coordinated input to the nucleus,
such as that which occurs during vagal reflex initiation, might also render the region
susceptible to spreading depolarization in mice with TLE. GABAergic NTS neurons
play a critical role as mediators of cardiac, respiratory, and baroreceptor reflexes
(Andresen and Kunze, 1994; Kanter et al., 1995; Wang et al., 2001a; Wang et al.,
2001b; Zoccal et al., 2014). Because we did not see any cardiac-specific
phenotypes in the mice with pilocarpine-induced TLE, we hypothesize that the
increase in NTS neuron excitability leads to an increased propensity for
depolarization block and spreading depression centrally, resulting in sudden death
under specific conditions (Aiba and Noebels, 2015). Notably, this is not necessarily
superimposed on chronic changes in cardiac function in this model. These central

70

mechanisms may lead to aberrant baroreceptor or cardiorespiratory reflexes in the
pilo-SE mice, but intrinsic changes in cardiac function may not be expressed under
nominal conditions.
The present results show that mice that survive SE are susceptible to
SUDEP after several weeks. Our findings are consistent with the hypothesis that
glutamate release is persistently elevated in the NTS after SE, evidenced by an
increase in glutamatergic synaptic input to GABAergic NTS neurons and a
corresponding increase in neuronal activity. Chronically increased activity in
GABAergic NTS neurons would be expected to impact parasympathetic or
sympathetic tone, autonomic reflexes, including cardiorespiratory reflexes, and
may underlie seizure-induced depolarization block and spreading depression in
the nucleus, leading to cardiorespiratory collapse and SUDEP. Our results also
suggest multiple components contribute to the altered excitation of NTS GABA
neurons, including an initial increase in glutamate release driven by action
potentials in local neurons and a delayed, persistent increase in presynaptic
glutamate release from synaptic terminals of central neurons. These changes likely
involve seizure-induced synaptic or channel reorganization within the central vagal
system. Although the mechanistic cause of SUDEP per se has been debated
(Surges and Sander, 2012; Ryvlin et al., 2013; Aiba and Noebels, 2015), it is most
likely not due to a single etiology such as cardiac changes, at least in mice with
TLE. We posit that in TLE, SUDEP may result from multiple factors (e.g. cardiac
or respiratory failure), and the triggers for these are superimposed on dysregulated
NTS circuits. Understanding the cellular changes in the NTS that are associated
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with seizures may prompt the development of predictive biomarkers for SUDEP in
those populations most at risk, and eventually therapies to prevent SUDEP.
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Chapter 4 Alterations in A-type current in the nucleus tractus solitarius in
acquired temporal lobe epilepsy

4.1

Introduction
Approximately 60% of all individuals with epilepsy have temporal lobe

epilepsy (TLE), which is characterized by recurrent, unprovoked electrical activity
originating in the medial portions of the temporal lobe. In about 30% of these
individuals, seizures are medically intractable. Sudden Unexpected Death in
Epilepsy (SUDEP) is defined as when an individual who is otherwise healthy, dies
suddenly and unexpectedly for unknown reasons and is one of the leading causes
of death in individuals with epilepsy and risk is increased in patients with
uncontrolled seizures (Annegers, 1997; Nashef, 1997; Nashef et al., 2012;
Tolstykh and Cavazos, 2013; Ellis and Szabo, 2018). Previous studies in mouse
models of genetic epilepsy have suggested that functional seizure-related that
alterations in brainstem centers that modulate peripheral autonomic and
cardiorespiratory reflexes are associated with an increased risk for SUDEP
(Goldman et al., 2009; Glasscock et al., 2010; Cheah et al., 2012; Kalume et al.,
2013; Simeone et al., 2018). It has also been shown in mouse models of genetic
epilepsy that seizures can spread from the cortex to the brainstem, leading to
cardiorespiratory collapse and sudden death (Aiba and Noebels, 2015).
Importantly, we have recently shown in a model of acquired TLE that aminobutyric acid (GABA) neurons in the nucleus tractus solitarius (NTS), the
primary central autonomic integration area in the caudal brainstem, are
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hyperexcitable in a mouse model of TLE, which may contribute to increased
SUDEP risk in this model (Derera et al., 2017).
The NTS is located in the dorsal vagal complex of the caudal brainstem and
is the principal central locus of visceral autonomic integration. NTS neurons
receive primary glutamatergic inputs from vagal afferent fibers and project their
axons to preganglionic parasympathetic motor neurons in the dorsal motor nucleus
of the vagus (DMV) and the nucleus ambiguus (NA) (Andresen and Kunze, 1994;
Doyle and Andresen, 2001; Wang et al., 2001b; Davis et al., 2004; Travagli et al.,
2006; Glatzer et al., 2007; Browning and Travagli, 2010). Neurons of the NTS
project to the hypothalamus and pre-sympathetic areas of the ventral brainstem as
well; therefore the nucleus is well-situated to regulate premotor sympathetic and
parasympathetic output (Takenaka et al., 1995; Fontes et al., 2001; Irnaten et al.,
2001; Affleck et al., 2012; Zoccal et al., 2014). NTS neurons have been shown to
alter their function in response to many disease states, including hypertension,
hypoxia, and diabetes, and a reduction in voltage-gated K+ current as been shown
to be associated with these pathologies (Mei et al., 2003; Kline et al., 2005; Bach
et al., 2015; Boychuk et al., 2015a). While voltage-gated K+ currents have been
investigated in hypertension and hypoxia (Belugin and Mifflin, 2005; AccorsiMendonca et al., 2015), epilepsy-related changes in voltage-gated K+ currents of
NTS neurons have not been examined in a mouse model of acquired TLE. We
postulate that a portion of the hyperexcitability previously seen in GABAergeric
NTS neurons in TLE may be due to a similar reduction in voltage-gated K+ current.
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Several voltage-gated K+ channels are known to be associated with
epilepsy and are expressed in NTS neurons (Moak and Kunze, 1993; Kline et al.,
2005; Ramirez-Navarro et al., 2011; Villa and Combi, 2016). Of particular interest
is the Kv4 family of voltage-gated K+ channels, which underlie the A-type K+ current
in NTS neurons (Belugin and Mifflin, 2005; Bailey et al., 2007; Strube et al., 2015).
Voltage-gated K+ channels play a major role in neuronal excitability and K+
channelopathies can contribute to seizures (Brenner and Wilcox, 2012; D'Adamo
et al., 2013; Villa and Combi, 2016). The Kv4 family of voltage-gated K+ channels
prevent action potential back-propagation and regulate neuronal excitability
(Birnbaum et al., 2004). There are three subunits that comprise the Kv4 subfamily:
Kv4.1, Kv4.2, and Kv4.3. There are also four K+ channel interacting proteins
(KChIPs) that can modulate Kv4 activity and surface expression (Birnbaum et al.,
2004; Covarrubias et al., 2008). The Kv4.2 subunit has specifically been
associated with TLE and mutations in KCND2, which encodes for the Kv4.2
subunit, have been shown to occur in individuals diagnosed with TLE (Singh et al.,
2006; Lee et al., 2014). Additionally, when Kv4.2 is deleted in mice, susceptibility
to kainite-induced seizures is increased (Barnwell et al., 2009). Several studies
have shown a downregulation in Kv4.2, KChIPs, and A-type K+ currents following
pilocarpine-induced status epilepticus (SE). Importantly, these changes occurred
not only in the days following SE, but in the chronic seizure phase, months postSE (Lugo et al., 2008; Monaghan et al., 2008; Su et al., 2008). However, A-type
K+ current has not been examined in NTS neurons in a mouse model of TLE.
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We hypothesize that there is an alteration in A-type K+ current and Kv4
expression is associated with increased excitability of GABAergic NTS neurons
that develops during temporal lobe epileptogenesis. Increased excitability in this
neuronal subtype may decrease the threshold for spreading depolarization,
leading to an increased risk for cardiorespiratory collapse and SUDEP. We used
the pilocarpine-induced SE model of TLE to test this hypothesis (Shibley and
Smith, 2002; Winokur et al., 2004; Derera et al., 2017).
4.2

Methods
4.2.1

A-Type Potassium Current Recordings

A-type K+ current (IA) activation and inactivation were measured in
GABAergic NTS neurons using a series of voltage-step protocols. Total K+ currents
(IK) were determined using the following protocol: from holding potential (-70 mV),
a 500 ms hyperpolarizing pre-pulse (-110 mV) was delivered followed by a series
of depolarizing voltage steps (-60 mV to +30 mV; 500 ms; 10 mV increments),
evoking transient and sustained outward currents. The delayed rectifier K + current
(IKDR) was determined by delivering a 500 ms depolarizing pre-pulse at -30 mV
from holding potential (-70 mV) followed by 500 ms depolarizing voltage steps from
-60 mV to +30 mV in 10 mV increments. IA was calculated by offline subtraction of
IKDR from IK in Clampfit 10.3 (Molecular Devices). IA inactivation was revealed with
the following protocol: from holding potential (-70 mV), conditioning steps from
-120 mV to +60 mV (10 mV increments, 500 ms duration), were followed by a test
pulse at -30 mV (500 ms duration). The ACSF for all IA recordings contained
tetrodotoxin (TTX, 1 µM), bicuculline (BIC, 30 µM), kynurenic acid (KYN, 1mM),
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and tetraethylammonium chloride (TEA-Cl, 10 mM). In order to confirm the
presence of IA, 4-AP (5mM) was added to the ACSF, and the activation and
inactivation protocols were repeated. Current is presented as pA/pF in order to
adjust for differences in cell size. Series resistance was less than 15 MΩ and
compensated between 30% and 70% for all recordings. Series resistance was
evaluated between each voltage-step protocol to ensure cell health.
4.2.2 qRT-PCR
Three to four brainstem slices per animal that contained the vagal complex
(300 µM) were isolated as previously described for electrophysiological recordings.
The vagal complex, including the NTS, was visualized under a dissecting
microscope and excised from the rest of the brainstem using a 1 mm diameter
punch (Miltex Inc., York, PA). This approach allowed for a more homogenous
tissue sample with minimal sampling from other brainstem areas (Boychuk et al.,
2015a; Halmos et al., 2015; Boychuk et al., 2017). Tissue samples from one animal
were pooled into one sample. RNA was isolated using the RNeasy miniPrep kit
(Qiagen, Hilden Germany). Spectrophotometry (ThermoScientific, NanoDrop 2000
Spectrophotometer) was used to determine cDNA quality and quantity. All qRTPCR reactions were run in triplicate in 96-well optical grade plates using a 7500
Fast Real-Time PCR System (Applied Biosystems, Foster City, CA). Total volume
for each run was 20 µL containing 50-100 ng of cDNA. The reaction times and
temperatures were 50˚C for 2 minutes, 95 ˚C for 10 minutes, followed by 50 cycles
of 95 ˚C for 15s, and 60 ˚C for 1 minute. Primers and probe sets for -actin
(Mm.PT.39a.22214843), Kv4.1(mostly microglia; Mm.PT.58.1430675), Kv4.2
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(oligodendrocytes

and

Mm.PT.58.7819122,

neurons;

KChIP1

Mm.PT.58.29624161),

(neurons;

Kv4.3

(neurons);

Mm.PT.58.41994313),

KChIP3

(astrocytes; Mm.PT.58.43828062) and KChIP4 (neurons; Mm.PT.58.9880505)
were purchased from Integrated DNA Technologies (IDT, Skokie, IL). Fold change
in each gene of interest was calculated using the formula 2 -CT; -actin was used
as a reference gene. Water-only (i.e. no primer/probe) and no-RT controls were
also run in each reaction. The positive control contained the whole brainstem
instead of the vagal complex tissue sample (Livak and Schmittgen, 2001). The
CT was used to determine statistical significance using an unpaired t-test (Wood
and Giroux, 2003).
Methods for Chapter 4 also included: methylscopolamine and pilocarpine
injections,

brainstem

slice

preparation,

and

whole-cell

patch-clamp

electrophysiology as described in Chapter 2 of this dissertation.
4.3

Results
4.3.1 Action potential frequency and half-width are altered in GABAergic
NTS neurons from Pilo-SE mice
In order to investigate the hyperexcitability seen in GABAergic NTS neurons

during epileptogenesis, we assessed action potential firing frequency and halfwidth in control and pilo-SE mice 9-12 weeks post-treatment. Action potential
frequency was significantly greater in GABAergic NTS neurons from pilo-SE mice
(2.54  0.37 Hz, n = 10 cells) compared to control mice (1.46  0.24 Hz, n = 11
cells, p = 0.03, Fig. 4.1A,C). When measured at a membrane potential of -70 mV,
action potential half-width was significantly greater in GABAergic NTS neurons
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from pilo-SE mice (2.14  0.16 ms, n = 10 cells) compared to control mice (1.69 
0.13 ms, n = 11 cells, p = 0.04, Fig. 4.1B,D). The increase in action potential halfwidth in neurons from pilo-SE mice is suggestive of a lengthening in the
repolarization phase of the action potential.
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Figure 4.1 GABA NTS neurons from pilo-SE mice have increased action potential
firing frequency and half-width.
(A) Representative traces showing action potential firing in GABAergic NTS
neurons from a control and pilo-SE animal. (B) Representative traces showing
action potential half-width in GABAergic NTS neurons from a control and pilo-SE
animal. (C) Action potential frequency is significantly increased in GABAergic NTS
neurons from pilo-SE mice (unpaired t-test; *p < 0.05). (D) Action potential halfwidth is significantly increased in GABAergic NTS neurons from pilo-SE mice
(unpaired t-test; *p < 0.05).
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Various families of voltage-gated K+ channels modulate the repolarization
phase of the action potential. We hypothesized that in pilo-SE mice there may be
a decrease in voltage-gated K+ channel function that contributes to both the
increase in the action potential half-width and the hyperexcitability seen in
GABAergic NTS neurons. In order to test this hypothesis, we measured action
potential frequency and half-width before and after bath application of 4-AP (5
mM), a voltage-gated K+ channel blocker, in GABAergic NTS neurons from control
and pilo-SE mice 9-12 weeks post-treatment. Action potential frequency was
significantly greater after application of 4-AP in GABAergic NTS neurons from
control mice (no 4-AP: 1.56  0.31 Hz, n=13 cells; after 4-AP: 3.1  0.65 Hz, n= 6
cells, p = 0.02). However, there was no significant difference in action potential
frequency in GABAergic NTS neurons in normal ACSF (3.20  0.32, n = 13 cells)
and after application of 4-AP (4.39  0.82, n= 8 cells, p = 0.13 Fig. 4.2). When
examining action potential half-width, we found that it was significantly longer after
application of 4-AP in GABAergic NTS neurons control mice (before 4-AP: 1.63 
0.15 ms, n=8 cells; after 4-AP: 3.52  0.42ms, n= 5 cells, p = 0.0005). We did not
detect a significant difference in action potential half-width in GABAergic NTS
neurons from pilo-SE mice in the absence (2.63  0.44 ms, n= 10 cells) or presence
(2.90  0.22 ms, n= 6 cells, p = 0.66, Fig. 4.3) of 4-AP. The decrease in sensitivity
to 4-AP seen in GABAergic NTS neurons from pilo-SE mice suggests that there
may be a decrease in the function of voltage-gated K+ channels, potentially those
contributing to the A-type current.
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Figure 4.2 The effect of 4-AP on action potential firing frequency in GABA NTS
neurons.
(A) Representative trace showing action potential firing in a GABA NTS neuron
from a control animal in normal ACSF (nACSF). (B) Action potential firing in the
same GABA NTS neuron in the presence of 4-AP (5mM). (C) Representative trace
showing action potential firing in a GABA NTS neuron from a pilo-SE mouse in
nACSF. (D) Representative trace showing action potential firing in the same GABA
NTS neuron in the presence of 4-AP. (E) Action potential frequency is significantly
higher after application of 4-AP in GABA NTS neurons form control mice. There is
no significant difference in action potential frequency before and after 4-AP
application in GABA NTS neurons from pilo-SE mice (unpaired t-test; *p < 0.05).
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Figure 4.3 GABA NTS neurons from pilo-SE mice are less sensitive to 4-AP.
(A) Representative traces showing action potential half-width in a GABAergic NTS
neuron from a control animal in normal ACSF (nACSF) and in the presence of 4AP (5mM). (B) Representative traces showing action potential half-width in a
GABAergic NTS neuron from a pilo-SE mouse in nACSF and in the presence of 4AP. (C) Action potential half-width is significantly increased in GABAergic NTS
neurons from control mice after 4-AP application. There is no significant difference
in action potential half-width before and after 4-AP application in GABA NTS
neurons from pilo-SE mice (unpaired t-test; *p < 0.05).
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4.3.2 The effect of 4-AP on sEPSC frequency and amplitude in
GABAergic NTS neurons
We also assessed the effect of 4-AP on frequency and amplitude of
sEPSCs in GABAergic NTS neurons from control and pilo-SE mice 9-12 weeks
post-treatment. There was a significant increase in sEPSC frequency in
GABAergic NTs neurons after application of 4-AP (before 4-AP: 1.17  0.23 Hz,
n= 7 cells; after 4-AP: 5.34  0.78 Hz, n= 7, p = 0.003). sEPSC frequency was not
significantly different following 4-AP application (before 4-AP: 3.77  0.87 Hz, n=
6 cells; after 4-AP: 4.54  0.74 Hz, n= 14 cells, p = 0.55). Application of 4-AP had
no significant effect on sEPSC amplitude in either control or pilo-SE mice (control:
p = 0.59; pilo-SE: p = 0.67; Fig. 4.4). Changes in synaptic frequency with addition
of 4-AP are consistent with previous studies in both the hippocampus (Buckle and
Haas, 1982) and NTS (Haji and Ohi, 2010), and the absence of detectable change
in pilo-SE mice suggests a functional reduction in 4-AP sensitive channels in
GABA NTS neurons.
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Figure 4.4 The effect of 4-AP on sEPSC frequency and amplitude in GABA NTS
neurons.
(A, B) Representative traces showing sEPSCs in a GABA NTS neuron from a
control animal in normal ACSF (nACSF) and in the presence of 4-AP (5mM). (C,D)
Representative traces showing sEPSCs in a GABA NTS neuron from a pilo-SE
animal in nACSF and in the presence of 4-AP. (E) There is significantly higher
sEPSC frequency in GABA NTS neurons from control mice after 4-AP and no
significant difference in pilo-SE mice after 4-AP application (unpaired t-test; *p <
0.05). (F) There is no significant difference in sEPSC amplitude before and after
4-AP application in GABA NTS neurons from control or pilo-SE mice (unpaired ttest; p > 0.05).
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4.3.3 A-type potassium current is reduced in GABA NTS neurons from
pilo-SE mice
Since 4-AP is a specific blocker of A-type K+ currents, we hypothesized that
the decrease in sensitivity to 4-AP in pilo-SE mice may be due a decrease in Atype K+ current. First, we assessed the amplitude of the transient outward currents
(TOCs) in GABAergic NTS neurons from control and pilo-SE mice. The membrane
capacitance was not different between GABAergic NTS neurons from control and
pilo SE mice (control: 6.57  0.20 pF; pilo-SE: 7.39  0.79 pF; p = 0.14). The series
resistance also did not differ between groups (control: 8.69  0.76 MΩ; pilo-SE:
7.86  1.29 MΩ; p = 0.59). The amplitude of the TOCs (measured 20-30 ms after
the voltage step onset) were significantly different between GABAergic NTS
neurons from control and pilo-SE mice (F (9,160) = 1.96, P = 0.04, control n= 10
cells, pilo-SE n=8 cells, Fig 4.5C). At activation voltages from +10 to +30 mV, the
TOCs were significantly reduced in GABAergic NTS neurons from pilo-SE mice
compared to control mice (+10 mV: p = 0.04; +20 mV: p = 0.01; +30 mV: p = 0.003).
We did not see any significant differences in longer-lasting steady state amplitude
in GABAergic NTS neurons between control and pilo-SE mice (F 9,160) = 0.18, P
= 0.99, Fig 4.5D), measured in the last 50 ms of the voltage step. In a separate
cohort of GABAergic NTS neurons, 4-AP was added to the bath solution in order
to validate that the A-type voltage-gated K+ current was being measured (Fig 4.6).
We also examined the voltage dependence of activation and inactivation in
GABAergic NTS neurons from control and pilo-SE mice. There was no significant
difference in the voltage dependence of activation (2-way ANOVA, F (9,330) =
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0.21, p = 0.99, Fig 4.7A) or inactivation (2-way ANOVA, F (18, 475) = 0.18, p =
0.99, Fig 4.7B) in GABAergic NTS neurons from control mice and pilo-SE mice.
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Figure 4.5 Transient outward current amplitude is reduced in pilo-SE mice.
(A) Representative trace of IA activation in a GABAergic NTS neuron from a control
animal. (B) Representative trace of IA activation in a GABAergic NTS neuron from
a pilo-SE animal. (C) Mean amplitude of TOCs (measured as peak-steady state
values). GABA NTS neurons from pilo-SE mice had significantly lower TOCs
compared to those from control mice (2-way ANOVA, *P < 0.05). (D) There was
no significant difference in steady-state outward currents in GABA NTS neurons
from control and pilo-SE mice (2-way ANOVA, p > 0.05).
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Figure 4.6 The effect of 4-AP on transient outward current amplitudes in
GABAergic NTS neurons.
(A) Representative trace of IA activation in a GABAergic NTS neuron from a
control animal in normal ACSF (nACSF) and in the presence of 4-AP (5 mM). (B)
Representative trace of IA activation in a GABAergic NTS neuron from a pilo-SE
animal in nACSF and in the presence of 4-AP. (C) 4-AP significantly reduced
TOCs in GABAergic NTS neurons from both control and pilo-SE mice (2-way
ANOVA, *p < 0.05).
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Figure 4.7 Activation and Inactivation of TOCs in GABAergic NTS neurons from
control and pilo-SE mice.
(A) Voltage dependence activation of TOCs in GABAergic NTS neurons from
control and pilo-SE mice. (B) Voltage dependence inactivation of TOCs in
GABAergic NTS neurons from control and pilo-SE mice. (2-way ANOVA, p >
0.05).
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4.3.4 Quantitative reverse transcriptase PCR
Quantitative RT-PCR was utilized to determine if the reduction in IA is due
to a down regulation in the expression of the genes that encode the Kv4 subfamily
of voltage-gated K+ channels and their associated accessory subunits, KChIP1,
KChIP3, and KChIP4. There were no significant differences in the expression of
any Kv4 genes or their associated accessory subunits in pilo-SE mice relative to
control mice (Kv4.1: p = 0.81; Kv4.2: p = 0.83; Kv4.3: p = 0.81; KChIP1: p = 0.61;
KChIP3: p = 0.40; KChIP4: p = 0.47; Fig. 4.8).
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Figure 4.8 Kv4 and KChIP expression levels in the vagal complex from control
and pilo-SE mice.
There was no significant difference in expression of Kv4.1, Kv4.2, Kv4.3, KChIP1,
KChIP2, KChIP3, or KChIP4 (Unpaired t-test, p > 0.05). These analyses were
performed by Dr. Katalin Smith.
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4.4

Discussion
The present study investigated the 4-AP sensitive A-type voltage-gated K+

current in a mouse model of pilocarpine-induced TLE. Previous studies have
shown that there is a downregulation in the A-type current as well as voltage-gated
K+ channel protein in the hippocampus of pilocarpine-treated mice. This change
was seen both in the hours and months following SE induction (Lugo et al., 2008;
Monaghan et al., 2008; Su et al., 2008). SUDEP in genetic epilepsy models
established by Kv1.1 channelopathy have been described in the NTS (Glasscock
et al., 2010; Vanhoof-Villalba et al., 2018). Since the channelopathies induced the
epilepsy phenotype, however, the relevance of the seizure disorder to autonomic
dysfunction and SUDEP cannot be easily separated from the effect of the channel
mutation itself in these models. Conversely, the functional modification of voltagegated channels described here develops concurrently with epileptogenesis,
implying that epilepsy-related changes in channel function can contribute to central
vagal dysfunction in acquired epilepsy.
There have been several previous studies examining functional plasticity of
NTS neurons in other disease states (Mei et al., 2003; Belugin and Mifflin, 2005;
Kline et al., 2005; Dergacheva et al., 2013; Bach et al., 2015; Boychuk et al.,
2015a; Boychuk and Smith, 2016). We have also recently shown that in the
pilocarpine-induced SE model of TLE, GABAergic NTS neurons display
hyperexcitability 6 and 12 weeks post-SE (Derera et al., 2017). The A-type current
has been described in NTS neurons (Moak and Kunze, 1993; Bailey et al., 2002;
Bailey et al., 2007) and prominently regulates neuronal excitability and action
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potential morphology and repolarization. We first examined action potential
frequency and half-width and found that they were significantly increased in
GABAergic NTS neurons from pilo-SE mice compared to control mice suggesting
a decrease in the function of the voltage-gated K+ currents that underlie action
potential repolarization develops during epileptogenesis. More specifically, the
decrease in sensitivity of GABAergic NTS neurons from pilo-SE mice to 4-AP
suggests a reduction in A-type voltage-gated K+ current and Kv4 channel function.
The effect of 4-AP on synaptic activity in GABAergic NTS neurons between
control and pilo-SE mice was also assessed. We found that 4-AP elicited a
significant increase in sEPSC frequency, consistent with an increase in
presynaptic excitatory neurotransmission. This effect of 4-AP has previously been
shown in CA1 pyramidal neurons, as well as in NTS neurons involved in the cough
reflex (Buckle and Haas, 1982; Gu et al., 2004; Haji and Ohi, 2010). Interestingly,
we did not observe a similar increase in sEPSC frequency in GABAergic NTS
neurons from pilo-SE mice. These neurons already receive an increase in
excitatory neurotransmission (Derera et al., 2017), and combined with the
alterations in voltage-gated K+ current, may contribute to the lack of effect of 4-AP
in neurons from pilo-SE mice. Similar to what was reported by others (Haji and
Ohi, 2010), there was no significant effect of 4-AP on sEPSC amplitude in either
group. Overall, the exact mechanism as to why there is not a significant increase
in sEPSC frequency with 4-AP in pilo-SE mice, needs to be fully elucidated and
the increase in excitatory neurotransmission may be one factor of many that is
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contributing to the hyperexcitability of GABAergic NTS neurons in this model of
TLE.
The Kv4 subfamily of voltage-gated K+ channels is the primary regulator of
the A-type current and includes the Kv4.1, Kv4.2, and Kv4.3 subunits, which are
widely expressed in brain tissue (Rudy, 1988; Salkoff et al., 1992; Birnbaum et al.,
2004; Covarrubias et al., 2008). More specifically, immunolabelling has revealed
the presence of Kv4.2 and Kv4.3 subunits in neurons of the NTS (Strube et al.,
2015). Our data on average TOC amplitude and voltage dependence of activation
and inactivation in control animals are consistent with results from previous studies
in NTS neurons (Moak and Kunze, 1993; Bailey et al., 2002). Interestingly, we
found a reduction in average TOC amplitude in GABAergic NTS neurons from piloSE mice, but no changes in voltage-dependent activation or inactivation were
observed. This suggests that there may be a decrease in the number of voltagegated K+ channels at the membrane, rather than an alteration in the channel or
voltage-sensing pore contributing to a reduction in the A-type current amplitude.
The cellular mechanisms involved in Kv4 membrane expression and
function in TLE in the NTS remains to be elucidated. We did not detect a significant
decrease in the molecular expression of Kv4.1, Kv4.2, or Kv4.3 in pilocarpinetreated mice relative to control mice. IA can also be modulated via KChIPs, which
associate with Kv4 subunits and increase their surface expression and
conductance (Hoffman et al., 1997; Beck et al., 2002; Lien et al., 2002; Birnbaum
et al., 2004; Covarrubias et al., 2008). Previous studies suggest that expression of
these accessory subunits is reduced in pilocarpine-treated mice (Monaghan et al.,
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2008; Su et al., 2008). Upon measuring mRNA levels of KChIP1, KChIP3, and
KChIP4 there was no significant difference in expression in pilocarpine-treated
mice relative to controls. Kv4 function and expression can be altered in several
different ways other than through accessory subunit modulation. A decrease in the
export of Kv4 subunits from the endoplasmic reticulum, potentially via
phosphorylation of the PDZ domain of the channel can also decrease surface
expression of the channel (Birnbaum et al., 2004). Once the Kv4 channel is
shuttled from the endoplasmic reticulum to the membrane, surface expression and
channel opening can also be modified through phosphorylation by several kinases,
including protein kinase C (PKC), protein kinase A (PKA), calmodulin-dependent
protein kinase II (CAMKII), extracellular signal-related kinases/mitogen-activated
protein kinases (ERK/MAPK), and protein tyrosine kinase (PTK) (Birnbaum et al.,
2004). It has been shown in kainate-induced SE, that a decrease in the surface
expression Kv4.2 correlates with ERK phosphorylation of the channel suggesting
additional mechanisms for a decrease in the A-type current associated with
epilepsy (Lugo et al., 2008). An increase in PKC-mediated phosphorylation in
concert with a decrease in channel expression has been shown to be associated
with a reduction of IA in a rat model of TLE (Bernard et al., 2004). Other posttranslational modifications, such as glycosylation and palmitoylation are known to
increase channel stability and enhance surface localization of the channel
(Birnbaum et al., 2004), but if and how this may occur during epileptogenesis is
unclear.
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This region of the brain has played a significant role in the research for
potential SUDEP mechanisms. A previous study using genetic epilepsy models
has showed that after a chemically-induced cortical seizure spreads to the
brainstem, NTS neurons undergo spreading depolarization and the animal suffers
from cardiorespiratory collapse and death (Aiba and Noebels, 2015). In other brain
regions, increases in neuronal excitability have been associated with a decreased
threshold for spreading depression (Somjen, 2001; Dreier and Reiffurth, 2015).
Additionally, previous studies in individuals with TLE have shown evidence of Kv4
modification (Villa and Combi, 2016). We propose that reduced A-type current
contributes to the increase in GABA NTS neuron hyperexcitability seen during TLE
and that this may increase the risk for cardiorespiratory collapse. Understanding
both the cellular mechanisms and functional consequences of alterations in the Atype current in the context of TLE and SUDEP may allow for the development of
novel biomarkers and/or treatment options for individuals at risk of sudden death.
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Chapter 5 Chemogenetic manipulation of GABA NTS neurons in TLE
5.1

Introduction
Sudden unexpected death in epilepsy (SUDEP) is one of the leading causes

of death in individuals with temporal lobe epilepsy (TLE), which comprises 60% of
the total epilepsy population (Nashef, 1997; Tolstykh and Cavazos, 2013). Patients
with TLE display autonomic dysfunction such has depressed heart rate variability
and abnormal cardiac rhythms (Tomson et al., 1998; Mayer et al., 2004; Ronkainen
et al., 2005; Suorsa et al., 2011; Romigi et al., 2016). Additionally, studies utilizing
genetic epilepsy models have suggested that dysfunction in central autonomic
control centers in the caudal brainstem are involved in SUDEP (Glasscock et al.,
2010; Aiba and Noebels, 2015).
The autonomic nuclei that receive information regarding cardiorespiratory
function and subsequently modulate output to the periphery are located in the
dorsal vagal complex (DVC) of the causal brainstem. The DVC receives
viscerosensory information via the afferent fibers of the vagus nerve, which
synapse onto neurons in the nucleus tractus solitarius (NTS). NTS neurons project
to preganglionic motor neurons within the nucleus ambiguus and dorsal motor
nucleus of the vagus (DMV) to regulate parasympathetic output (Andresen and
Kunze, 1994; Doyle and Andresen, 2001; Wang et al., 2001b; Davis et al., 2004;
Glatzer et al., 2007). We have recently shown that GABAergic neurons in the NTS
are hyperexcitable in a mouse model of TLE (Derera et al., 2017). However, it is
still unknown if direct GABAergic NTS neuron activation is involved in seizures or
SUDEP.
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The aim of this study is to determine if selective activation of GABAergic
NTS

neurons

can

modulate

in

vivo

seizure

threshold

and

in

vitro

electrophysiological properties of neurons within the DVC. An excitatory designer
receptor exclusively activated by designer drugs (DREADDs) was used to
selectively modulate GABAergic NTS neuron function in a mouse model of
pilocarpine-induced TLE. Excitatory DREADDS have been used to modulate
animal behavior in other brain regions and pathologies but have yet to been utilized
in a mouse model of TLE and SUDEP (Armbruster et al., 2007; Urban and Roth,
2015; Roman et al., 2017). We hypothesized that if GABAergic NTS neurons are
directly involved in TLE, activation of these neurons via an excitatory DREADD
may either induce a seizure or decrease seizure threshold in TLE mice.
5.2

Methods
5.2.1 Stereotaxic Injection of DREADD Virus
Four weeks after pilocarpine or vehicle treatment, age-matched Vgat-ires-

Cre mice were injected with the excitatory DREAAD, pAAV8-hSyn-DIOhM3D(Gq)-mCherry into the NTS (pAAV8-hSyn-DIO-hM3D(Gq)-mCherry was a
gift from Bryan Roth, Addgene, Cambridge, MA; plasmid #44361) (Krashes et al.,
2011). Mice were weighed and placed under 5% isofluorane and 1.5% 100% O 2
for initial anesthesia. Once the animal was fully anesthetized, isofluorane was
reduced to 2.5 % with 1.5% 100% O2 and the animals head was shaved. Animals
were then placed in a stereotaxic device and given a subcutaneous injection of the
analgesic buprenorphine (0.1 mg/kg in 0.9% saline) to mitigate post-operative
pain. A midline incision was made across the scalp and bregma, lambda, and the
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occipital bone were exposed. Stereotaxic coordinates were measured from
bregma: AP: 7.0, ML: 0.1, DV: 0.36. A drill was used to make small hole (<1 mm
in diameter) at the injection site and 250-500 nL of pAAV8-hSyn-DIO-hM3D(Gq)mCherry was slowly injected into the NTS. Mice were given 1 mg/kg carprofen
post-operatively. After 10-14 days sutures were removed. Mice were used for in
vivo and in vitro studies 3-4 weeks after the injection of the DREADD.
5.2.2 Flurothyl-Induced Seizures
Flurothyl (Bis(2,2,2-trifluroethyl)ether (10% flurothyl in 95% ethanol; Sigma)
was used to induced a single acute seizure in Vgat-ires-Cre control and pilo-SE
mice 3 weeks after intracranial injection of pAAV8-hSyn-DIO-hM3D(Gq)-mCherry.
All experiments using flurothyl were performed within a certified fume hood. Mice
were given an i.p. injection of either saline mixed with DMSO or CNO (1mg/kg) 1520 minutes prior to being exposed to flurothyl. Each animal received the opposite
treatment 3-4 days later to have a counter-balanced design. The 10% flurothyl was
dripped at a rate of 6 mL/hour with a syringe pump (KD Scientific, Holliston, MA)
onto a gauze pad within the plexiglass container. One animal at a time was placed
in the container for each trial. Once the animal developed a seizure (i.e. loss of
posture), the flurothyl was stopped and the animal was exposed to open air, after
which the seizure ended (Kadiyala et al., 2016; Ferland, 2017; Kadiyala and
Ferland, 2017). Once the animal resumed normal behaviors (i.e. after five to 10
minutes), it was returned to its home cage and the latency to seize was recorded.
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5.2.3 Electrophysiological Recordings
Brainstem slices were transferred to a chamber mounted on a fixed stage
under an upright microscope (BX51WI; Olympus) where they were superfused with
continuously warmed (30-32C) oxygenated ACSF. VGAT-containing neurons in
the NTS that were transfected with pAAV8-hSyn-DIO-hM3D(Gq)-mCherry, were
mCherry-expressing and were targeted under epifluorescence (Krashes et al.,
2011). DMV neurons were targeted based on their morphological characteristics
(Bach and Smith, 2012; Bach et al., 2015). Patch pipettes for recordings were
pulled from borosilicate glass (open tip resistance 3-5 M; King Precision Glass
Co, Claremont, CA). The pipette solution contained (in mM): 130 K+ gluconate, 1
NaCl, 5EGTA, 10 HEPES, 1 MgCl2, 1 CaCl2, 3 KOH, 2 ATP. Recordings were
obtained using an Axon 700B amplifier (Molecular Devices; San Jose, CA), low
pass filtered at 2-3 kHz, digitized at 20 kHz, and recorded onto a computer
(Digidata 1440A, Molecular Devices).
Prior to recording, cells were allowed to equilibrate with the pipette
recording solution for approximately five minutes. Whole-cell patch clamp
recordings of spontaneous action potentials in NTS neurons were recorded in
current-clamp at resting membrane potential. Resting membrane potential was
recorded in I=0 in NTS neurons. Spontaneous inhibitory postsynaptic currents
(sIPSCs) were recorded in voltage-clamp in DMV neurons. DMV neurons were
clamped at a holding potential of 0 mV to isolate inhibitory currents. The effect of
clozapine-N-oxide (CNO, 30 M) was assessed on resting membrane potential
and action potential frequency in NTS neurons and on sIPSC frequency and
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amplitude in DMV neurons from control and pilo-SE mice. Series resistance was
less than 25 M and monitored periodically throughout the recordings. If the series
resistance changed by more than 20% over the course of a recording, it was
discarded.
5.2.4 Statistical Analyses
A repeated measures two-way ANOVA (Tukey’s post hoc) was used to
determine the effect of CNO treatment on flurothyl induced seizure latency
between control and pilo-SE mice (GraphPad Prism; La Jolla, CA). Action potential
frequency (2-minute recording segment) and resting membrane potential were
analyzed using Clampfit 10.2 (Molecular Devices). Two-minute segments of
continuous recordings of sIPSCs from DMV neurons was assessed with
MiniAnalysis (Synaptosoft, Decatur, GA). For electrophysiology data, a paired ttest was used to determine the effect of CNO on NTS and DMV neurons from
control and pilo-SE mice. Statistical significance for all measurements was set at
p < 0.05.
Methods for Chapter 5 also included: mice used, methylscopolamine and
pilocarpine injections, and brainstem slice preparation as described in Chapter 2
of this dissertation.
5.3

Results
5.3.1 Spontaneous Seizures
It has been previously established in various mouse strains that pilocarpine-

induced SE leads to the development of chronic spontaneous seizures four to six
weeks after treatment (Shibley and Smith, 2002; Groticke et al., 2007). However,
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spontaneous seizure development has not yet been established in the Vgat-iresCre mouse strain. Mice were passively monitored for seizures as described in
Chapter 2 beginning at four weeks post-pilocarpine treatment. None of the mice
that received vehicle treatment or did not have SE developed spontaneous
seizures, whereas 100% of mice that survived pilocarpine-induced SE developed
spontaneous seizures (Table 5.1).
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Table 5.1 Development of spontaneous seizures.

Control (n=4)
Mice that survived SE (>
3 S3 seizures; n=3)
Mice that died during SE
(n=8)
Non-SE mice (n=3)

Occurrence in
SE survivors
100%
0%

Spontaneous Seizures
Days after SE to 1st
Spontaneous Seizure
48.67 ± 16.44 (range: 3061)
-

Seizure Rate
(seizures/h)
0
0.13 ± .04
0
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5.3.2 Effect of GABAergic NTS neuron activation on Flurothyl-Induced
Seizure Latency
Control and pilo-SE mice were randomly administered either CNO or saline
and the latency to seize upon flurothyl exposure was measured. Three to four days
later, animals that were previously given saline, received CNO treatment, and viceversa. A repeated measures two-way ANOVA showed a significant interaction
effect between saline and CNO administration in control and pilo-SE mice
(F(1,13)=5.71; p = 0.03). Pilo-SE mice had a significantly shorter seizure latency
(462  37 sec; n=7 mice) compared to control mice (609  38 sec; n=8 mice; p =
0.03) when administered saline. While CNO did not significantly alter seizure
latency in pilo-SE mice (saline: 462  37 sec; CNO: 482  37 sec; n=7 mice; p =
0.99), it did significantly shorten the seizure latency in control mice (saline: 609 
38 sec; CNO: 458  22 sec; p = 0.02, Fig.5.1).
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Figure 5.1 Chemogenetic modulation of seizure latency in control and pilo-SE
mice.
There was a significantly shorter latency to seize in pilo-SE mice (n=7) compared
to control mice (n=8) when treated with saline. CNO alone reduced seizure latency
in control mice, but this did not further shortern the latency in pilo-SE mice. (p >
0.05). Two-way repeated measures ANOVA: F (1,13) = 5.71; p = 0.03. *p < 0.05.
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5.3.3 GABAergic NTS neuron activation in control and pilo-SE mice
The effect of GABAergic NTS neuron activation on action potential
frequency and resting membrane potential was assessed in control and pilo-SE
mice. The resting membrane potential was significantly more depolarized after
CNO application in control mice (ACSF: -46.06 ± 1.48 mV; CNO: -42.57 ± 0.76
mV; p = 0.02, n= 10 cells, Fig. 5.2D). Activation of GABAergic NTS neurons from
pilo-SE mice also had a significantly depolarized resting membrane potential
(ACSF: -45.83 ± 0.82 mV; CNO: -41.21 ± 1.06 mV; p = 0.001; n=10 cells Fig. 5.2D).
In the same cells, the CNO-induced activation of GABAergic NTS neurons was
concomitant with an increase in action potential frequency in both control (ACSF:
1.72 ± 0.39 Hz; CNO: 2.36 ± 0.38 Hz; p = 0.03; n=10 cells) and pilo-SE mice
(ACSF: 2.49 ± 0.47 Hz; CNO: 3.90 ± 0.80 Hz; p = 0.03; n=10 cells; Fig. 5.2C).
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Figure 5.2 Chemogenetic modulation of GABAergic NTS neurons from control
and pilo-SE mice.
(A) Illustration of pipette location in the NTS. (B) Representative image of
mCherry expression in the NTS four weeks after DREADD injection. (C)
Representative traces showing the effect of clozapine-N-oxide (CNO, 30 µM) on
action potential firing in a GABAergic NTS neuron from a control animal. (D)
Representative traces showing the effect of CNO on action potential firing in
GABAergic NTS neuron from a pilo-SE animal. (E) CNO significantly increases
the action potential frequency in control mice and pilo-SE mice. (F) CNO
significantly depolarizes membrane potential in GABAergic NTS neurons from
control and pilo-SE mice. Sample Sizes: control: n=8 mice; pilo-SE: n=8 mice. *p
< 0.05.
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5.3.4 Inhibition of Vagal Motor Neurons via GABAergic NTS Neuron
Activation
GABAergic NTS neurons project to preganglionic parasympathetic motor
neurons in the DMV (Travagli et al., 1991; Davis et al., 2004; Babic et al., 2011).
We tested the hypothesis that activation of mCherry-expressing NTS neurons
would increase inhibition of DMV neurons, assessed via sIPSC frequency and
amplitude. GABAergic NTS neuron activation in slices from control animals
significantly increased sIPSC frequency (ACSF: 0.53 ± 0.1 Hz; CNO: 0.96 ± 0.21
Hz; p = 0.02) but not amplitude (ACSF: 36.97 ± 4.45 pA; CNO: 30.73 ± 1.75 pA; p
= 0.22; n=6 cells) of DMV neurons. There was a similar effect in DMV neurons
from pilo-SE mice, where sIPSC frequency increased (ACSF: 0.98 ± 0.35 Hz;
CNO: 1.72 ± 0.45 Hz; p = 0.001), but there was no significant change in amplitude
(ACSF: 43.39 ± 9.20 pA; CNO: 53.58 ± 19.28 pA; p = 0.48; n=8 cells; Fig. 5.3).
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Figure 5.3 Inhibition of preganglionic parasympathetic motor neurons in control
and pilo-SE mice.
(A) Representative traces showing the effects of CNO (30 µM) on sIPSCs in a
DMV neuron from a control mouse. (B) Representative traces showing the effect
of CNO on sIPSCs in a DMV neuron from a pilo-SE mouse. (C) Application of CNO
significantly increases sIPSC frequency in DMV neurons from control and and piloSE mice. (D) CNO does not significantly alter sIPSC amplitude in DMV neurons
from control and pilo-SE mice. Sample sizes: control: n=4 mice; pilo-SE: n=5 mice.
*p < 0.05.
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5.4

Discussion
Previous research has utilized DREADDs to excite or inhibit specific

neuronal subtypes in order to modulate whole animal behavior and neuron function
(Krashes et al., 2011; MacLaren et al., 2016; Roth, 2016; Whissell et al., 2016).
Inhibitory DREADDs have been used to block seizure activity in organotypic slice
cultures and kindling models (Avaliani et al., 2016; Wicker and Forcelli, 2016).
While blocking seizure activity with inhibitory DREADDs in these studies has been
successful, there have been no studies using excitatory DREADDs to induce
seizure activity. This study tested the hypothesis that activation of GABAergic NTS
neurons via the excitatory DREADD, pAAV8-hSyn-DIO-hM3D(Gq)-mCherry, can
modulate whole animal seizure threshold and single vagal complex neuron activity.
We first investigated the effect of DREADD-mediated activation of
GABAergic NTS neurons on animal behavior, namely on flurothyl-induced seizure
latency. When pilo-SE mice received no treatment, their latency to seize was
significantly shorter compared to control animals. While CNO did not appear to
have a significant effect on seizure latency in pilo-SE mice, it did significantly
reduce seizure latency in control mice.

This result was unexpected as I

hypothesized that CNO would decrease seizure latency in pilo-SE mice when
compared to control mice. Because GABAergic NTS neurons from pilo-SE mice
have been shown to become hyperexcitable, it is possible that there is a ceiling
effect, which could explain why CNO activation of mCherry-expressing NTS
neurons does not further shorten seizure latency. Control animals did not exhibit
any prior seizure activity and therefore may be more susceptible to a reduction in
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seizure latency when mCherry-expressing neurons are activated via CNO
administration. Aiba and Noebels have shown that when a seizure is chemically
elicited in the cortex of an anesthetized mouse with Dravet’s Syndrome, it spreads
to the brainstem initiating cardiorespiratory collapse and sudden death (Aiba and
Noebels, 2015). Additionally, they have shown that chemically-induced
depolarization of NTS neurons in Kv1.1 knockout mice results in seizure-like
waveforms and brief EEG suppression in the cortex. This suggests that spreading
depression in the brainstem effects cortical activity, supporting the hypothesis that
seizures propagation can affect NTS function and vice-versa, potentially
influencing SUDEP risk. Perhaps similar studies would be necessary for a seizure
in pilo-SE mice administered CNO to occur.
There has also been concern that CNO may not be as specific as initially
shown, as recent studies have suggested that CNO metabolizes into clozapine,
which may produce off-target effects (Gomez et al., 2017; Manvich et al., 2018).
While there is the possibility that this occurred in the whole animal studies, effects
of CNO were seen in less than 5 minutes during in vitro slice electrophysiology.
Electrophysiological results suggest that CNO increases excitation of GABAergic
NTS neurons, subsequently leading to increased inhibition of downstream motor
neurons that go on to regulate parasympathetic function. This would be expected
to increase the inhibition of parasympathetic output to the periphery, thus leading
to autonomic imbalance, similar to what is seen in patients with TLE (Ronkainen
et al., 2005; Romigi et al., 2016). Additionally, GABAergic NTS neurons were
slightly more sensitive to CNO-induced excitation (mV: control: 7.58%; pilo-SE:
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10.08%). This small differential effect may partially be due to epileptogenesis this
model.
These data show that pilo-SE mice have a reduced seizure latency and are
more easily excited by CNO compared to control animals, leading to increased
inhibition of preganglionic parasympathetic motor neurons. While CNO
administration decreased seizure latency in control mice, the lack of effect in pilomice suggests that increased excitability in GABAergic NTS neurons is not the sole
factor responsible for influencing seizure threshold and contributing to SUDEP.
Others have suggested that brainstem autonomic nuclei are the prime mediators
of SUDEP in models of genetic epilepsy (Glasscock et al., 2010; Aiba and Noebels,
2015), however, acquired epilepsies may be more complicated and SUDEP could
be due to a multitude of factors including altered respiratory function (Ryvlin et al.,
2013; Sowers et al., 2013; Zhan et al., 2016). More work needs to be done
examining the function of neurons in other brain regions that may contribute to
SUDEP in concert with autonomic nuclei. This would provide greater insights to
mechanisms of SUDEP and allow for the development of potential biomarkers or
preventative treatment options.
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Chapter 6 Discussion
6.1

Summary of Findings
This dissertation focused on alterations in GABAergic NTS neuron function

in a mouse model of pilocarpine-induced TLE and SUDEP. While several studies
have used genetic epilepsy models to study SUDEP (Faingold et al., 2010;
Glasscock et al., 2010; Cheah et al., 2012; Auerbach et al., 2013; Kalume et al.,
2013; Aiba and Noebels, 2015), this dissertation is the first to examine sudden
death and NTS neuron function in a model of acquired TLE. The main findings of
this dissertation are as follows: 1) the pilocarpine-induced SE model of TLE is a
model of SUDEP, 2) pilo-SE mice did not display long-term, chronic abnormal
heart rhythms or heart rate variability, 3) GABAergic NTS neurons display acute
(i.e. 1 week post-SE) and long-term (i.e. 6-12 weeks post-SE) hyperexcitability, 4)
reduced A-type current contributes to hyperexcitability, 5) chemogenetic activation
of GABAergic NTS neurons alone is not sufficient to induce a seizure or SUDEP,
but lowers seizure latency in control mice, 6) Activation of an excitatory DREADD
in GABAergic NTS neurons increases inhibition of preganglionic parasympathetic
motor neurons. This study is the first to examine the pilocarpine-induced SE model
of TLE in the context of SUDEP. This study is the first to quantify mortality rates
from SUDEP in pilo-SE mice. Additionally, these results indicate that GABAergic
NTS neurons, which modulate parasympathetic output to the periphery are
functionally altered in TLE mice, potentially contributing to SUDEP.
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6.2

The Pilo-SE model of TLE as a model of SUDEP
6.2.1 Survival of Pilo-SE mice
Many studies have examined SUDEP in the context of genetic epilepsies,

with a focus on channelopathies that are associated with seizures. In studies using
a mouse model of Dravet’s Syndrome, sudden death has ranged from postnatal
day 16 to postnatal day 150 (Yu et al., 2006; Cheah et al., 2012; Auerbach et al.,
2013; Cheah et al., 2013; Kalume et al., 2013). There does appear to be difference
in the onset of sudden death occurrences in a global heterozygous Nav1.1 knockin model (Yu et al., 2006) versus a cre-driven deletion of Nav1.1 (Cheah et al.,
2012). However, mice with genetic mutations to recapitulate Dravet’s Syndrome
only have a small number of seizures (e.g. 1-12 seizures total) before dying
suddenly (Ogiwara et al., 2007; Cheah et al., 2012; Auerbach et al., 2013). By
comparison, pilo-SE mice have approximately 2 seizures per day beginning at 4-6
weeks post-SE (Shibley and Smith, 2002; Groticke et al., 2007; Hunt et al., 2013).
KCNA1-null mice also experience behavioral seizures and SUDEP beginning at
postnatal day 14-21 (Glasscock et al., 2010), presumably as consequence of the
deletion of Kv1.1 potassium channels, but no data has been published regarding
seizure frequency prior to death (Gautier and Glasscock, 2015).
Not including mice that died 1-7 days post-SE, there is a 23% survival rate
150 days post-treatment in pilo-SE mice compared to control mice. Mice that died
within the week following pilocarpine treatment were not considered to have died
of SUDEP because they did not develop spontaneous seizures. Additionally, mice
begin to suffer from SUDEP 16 days post-SE, with 60% having died after 6 weeks
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(Derera et al., 2017). This study is the first to show the mice that develop and
survive status epilepticus go on to die of SUDEP.
6.2.2 Cardiac changes in pilo-SE mice
Individuals with TLE who are at risk for SUDEP or eventually die from
SUDEP display cardiac abnormalities such as increased heart rate, depressed
HRV, and arrhythmias (Mayer et al., 2004; Ronkainen et al., 2005; Suorsa et al.,
2011; Romigi et al., 2016). Mouse models of genetic epilepsy also display cardiac
abnormalities, such as in Dravet’s syndrome, where mice have increased heart
rate directly preceding sudden death (Auerbach et al., 2013). KCNA1 knockout
mice have arrhythmias and autonomic blockade decreases the frequency of
atrioventricular block, suggesting that a central autonomic change might be
responsible for these abnormal heart rhythms (Glasscock et al., 2010).
This dissertation examined heart rate and heart rate variability at 4 time
points: 24 hours pre-treatment, 24 hours post-treatment, 6 weeks, and 12 week
post-treatment in control and pilo-SE mice. While there was a significant increase
in heart rate and decrease in HRV 24 hours post-treatment in pilo-SE mice, there
were no significant differences in the later time points when animals should have
developed spontaneous seizure activity. Previous studies using the pilocarpineinduced SE model of TLE had examined heart rhythms and autonomic balance 12 weeks post-treatment and used rats instead of mice (Metcalf et al., 2009a; Bealer
et al., 2010; Bealer et al., 2011). At rest, mice have a significantly higher heart rate
compared to rats, which may contribute to heart rate differences seen in
pilocarpine-treated rats compared to mice (Lujan et al., 2012). Within 30 minutes
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of SE, there is a significant increase in heart rate in pilocarpine-treated rats
(Metcalf et al., 2009b). This increase persists 1 and 2 weeks post-SE (Metcalf et
al., 2009a). This study also concluded that a decrease in vagal tone, leading to a
dominance in sympathetic drive is responsible for autonomic imbalance and a
persistent increase in heart rate, increasing the risk for sudden death (Metcalf et
al., 2009a). Overall, alterations heart rate and HRV occur acutely in pilo-SE mice,
but more work needs to be done to determine if long-term changes occur as a
result of chronic spontaneous seizure activity resulting in increased SUDEP risk.
6.2.3 Future directions
While this study shows that pilo-SE mice die from SUDEP, it was unable to
pinpoint seizures in relation to sudden death or the actual death itself. It would
have been more impactful to record video-EEG in these animals. This would have
allowed for the exact time of death to be determined and record if a seizure event
directly preceded SUDEP. The video component would have been useful in
determining if there was any altered respiratory function, such as gasping behavior
after a seizure and/or prior to death.
In the future, the addition of video-EEG to the cardiac monitoring would be
a valuable way to decipher pre-, inter-, and post-ictal periods during a spontaneous
seizure occurrence. It would allow for more specific examination of cardiac
rhythms. For example, the use of EEG would allow for the comparison of heart rate
and HRV between seizure periods instead of during random time points, making
this study more similar to those examining individuals with epilepsy. This could
allow for more clear interpretation of autonomic alterations during epileptogenesis
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as well, because inter-ictal autonomic changes may be more predictive of SUDEP
risk than changes that occur surrounding a specific seizure event. The addition of
continuous ECG monitoring instead of only recording at 4 time points would also
be more informative of cardiac changes. There were 2 animals that were initially
part of this study that died suddenly just prior to the 8 weeks-post SE, but because
there was not continuous ECG recording, it was impossible to determine if cardiac
abnormalities occurred prior to death. Ultimately, these additions could allow for a
better interpretation of autonomic function over time in association with seizure
development.
6.3

Alterations in GABAergic NTS neuron excitability
6.3.1 Synaptic and intrinsic changes in GABAergic NTS neurons
GABAergic NTS neurons receive glutamatergic, or excitatory, input

primarily from the postsynaptic terminals in the afferent fibers of the vagus nerve
that terminate at the ST. Previous research shows that GABAergic NTS neurons
alter their function as a consequence of various pathological states such as
hypoxia and diabetes (Zsombok and Smith, 2009; Kline, 2010; King et al., 2012;
Boychuk et al., 2015a). This dissertation examined GABAergic NTS neuron
function in a mouse model of TLE and SUDEP. While there were no changes in
the resting membrane potential or input resistance of GABAergic NTS neurons
following pilocarpine-induced SE, there were significant alterations in the synaptic
properties of these neurons. One week post-SE these neurons displayed
significant increases in spontaneous action potential and sEPSC frequency. Even
more interesting, there appeared to be sustained long-term changes in excitability.
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This was evidenced by increases in spontaneous action potential, sEPSC, and
mEPSC frequency 6 and 12 weeks post-SE. Spontaneous and mEPSC frequency
increases were not accompanied by increases in amplitude, indicative of an
increase in excitatory neurotransmitter release from presynaptic terminals, such
as the vagal afferent terminals in the ST. Additionally, when the ionotropic
glutamate blocker kynurenic acid was applied to slices, there was a significant
decrease in excitability as indicated by a decrease in sEPSC frequency in
GABAergic neurons from pilo-SE mice.
A significant increase in mEPSC frequency but not amplitude is suggestive
of an increase in presynaptic release probability of glutamate (i.e. readily
releasable vesicle pool) or an increase in the number of functional synapses (Kline,
2008; Pinheiro and Mulle, 2008; Queenan et al., 2012). To test the hypothesis that
there was a change in either of these properties, paired pulse and frequencydependent depression was examined. It has been theorized that this type of
synaptic plasticity in the NTS serves to prevent excessive alterations to blood
pressure (Liu et al., 2000; Kline, 2008). While this dissertation is the first to examine
paired pulse and frequency-dependent depression in GABAergic NTS neurons in
a mouse model of TLE, there were no significant differences in either of these
parameters. Therefore, the increase in excitability seen in GABAergic NTS
neurons from pilo-SE mice is likely not due to an increase in the vesicle pool or an
increase in synapses stemming from vagal afferent terminals. Local glutamatergic
neurons within NTS circuitry can also influence GABAergic firing properties
(Champagnat et al., 1986; Kawai and Senba, 1996). For example, increases in the
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amount of excitatory neurotransmitter or slow turnover within the synaptic cleft can
also alter excitability (Chen and Bonham, 2005; Kline, 2008). Additionally, there
exists multiple subgroups within the NTS neuron population that are dependent on
the location of vagal afferent fiber terminals. Cardiovascular afferents terminate in
the lateral and medial NTS, while afferents from the stomach terminate in the
commissural NTS (Barraco et al., 1992; Babic et al., 2015). Electrophysiology
recordings of evoked EPSCs in paired pulse and frequency-dependent depression
studies did not differentiate between these subpopulations. Thus, recordings from
various NTS subpopulations may have confounded effects of presynaptic
glutamate release from vagal afferents.
6.3.2 Future directions
To examine vagal afferent firing properties further, future studies should
focus on GABAergic neurons within the lateral and medial NTS, in order to better
isolate alterations in synaptic plasticity from cardiovascular afferents. Additional
work could also be done examining local glutamatergic NTS neurons.
Immunohistochemical studies

labeling

vesicular glutamate

transporter 2

(VGLUT2), which is present in the NTS (Hermes et al., 2014; Bach et al., 2015),
would provide insight into the sites of origin for increased glutamate
neurotransmitter release. As labeling for VGLUT2 would also presumably label
vagal afferent terminals, this could allow for differentiation between glutamate
release in the ST versus local glutamatergic NTS neurons. To more closely
examine the structural relationship between presynaptic terminals from local
glutamatergic NTS neurons, VGLUT, and postsynaptic 2 nd order GABAergic NTS
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neurons, electron microscopy could be used. This could provide insight into the
differences in the number of glutamate vesicles in the presynaptic terminal
between control and pilo-SE solely in local glutamatergic NTS neurons. The
relationship between the potential modulation of excitatory neurotransmission onto
2nd order GABAergic neurons by local glutamatergic NTS neurons has not been
well-examined, and these future studies would provide insight from both basic
science and pathological perspectives.
6.4

Effects of TLE on voltage-gated K+ current in GABAergic NTS neurons
6.4.1 Reduced IA contributes to hyperexcitability in GABAergic NTS
neurons from pilo-SE mice
IA plays a prominent role in maintaining neuronal excitability by modulating

action potential repolarization (Mitterdorfer and Bean, 2002; Birnbaum et al.,
2004). IA is present in NTS neurons and has been altered in response to various
pathological in states (Moak and Kunze, 1993; Bailey et al., 2002; Belugin and
Mifflin, 2005; Bailey et al., 2007; Accorsi-Mendonca et al., 2015; Strube et al.,
2015). This dissertation examined the effects of 4-AP, an IA blocker, on action
potential frequency and half-width and also isolated IA in GABAergic NTS neurons.
GABAergic NTS neurons from pilo-SE mice displayed a decrease in sensitivity to
4-AP, while in contrast, GABAergic NTS neurons from control animals showed
significant increases in both action potential frequency and half-width. There was
also a significant increase in sEPSC frequency upon application of 4-AP. This
occurs

because

4-AP

depolarizes

pre-synaptic

terminals,

increasing

neurotransmitter release, which is similar to what others have seen in the
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hippocampus and NTS (Buckle and Haas, 1982; Gu et al., 2004; Haji and Ohi,
2010). Peak transient outward A-type current in GABAergic NTS neurons was
significantly reduced, with no changes in the kinetics of activation or inactivation in
pilo-SE mice compared to control mice. The lack of change in activation or
inactivation kinetics suggests that there is not a change in the voltage-sensing pore
region of the voltage-gated K+ channels (Birnbaum et al., 2004; Jerng et al., 2004).
This dissertation was first to examine IA in GABAergic NTS neurons in the
pilocarpine-induced SE model of TLE. It also shows that TLE can induce long-term
alterations in a crucial modulator of neuronal excitability.
6.4.2 Kv4 and KChIP expression in GABAergic NTS Neurons
It was hypothesized that the reduction in IA was due to a downregulation in
the expression of genes that encode the Kv4 family of voltage-gated K+ channels.
Kv4.1, Kv4.2, and Kv4.3 modulate the A-type current and can therefore affect IA
amplitude (Birnbaum et al., 2004; Strube et al., 2015). In one study a viral construct
was transfected into hippocampal cell cultures leading to a downregulation in
Kv4.2, as evidenced by action potential broadening and frequency increases (Kim
et al., 2005), similar to the electrophysiological data described in Chapter 4 of this
dissertation. When qRT-PCR was utilized to test for differences in expression in
Kv4.1, Kv4.2, and Kv4.3 there were no significant alterations in mRNA expression
in tissue samples from pilo-SE mice relative to control mice. This in contrast to
other studies examining the Kv4 subfamily in the hippocampus in TLE rodents,
which found decreases in Kv4.2 and Kv4.3 protein (Tsaur et al., 1992; Monaghan
et al., 2008; Su et al., 2008). However, a separate study found there were no
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changes in IA or Kv4.2 and Kv4.3 in pilocarpine-treated rats that developed
spontaneous seizure activity (Ruschenschmidt et al., 2006). KChIPs can also
modify the conductance of Kv4 channels (Beck et al., 2002; Birnbaum et al., 2004;
Covarrubias et al., 2008), so qRT-PCR was utilized to test for differences in
expression in KChIP1, KChIP3, and KChIP4. No significant differences were found
in any of the KChIPs in pilo-SE mice relative to controls. Again, this differs from
the literature where studies have shown a downregulation in KChIP1 months after
pilocarpine-induced SE (Monaghan et al., 2008; Su et al., 2008).
6.4.3 Future directions
There are several reasons why there may be a reduction in I A, suggestive
of increased excitability, without a concomitant decrease in Kv4 or KChIP
expression. Studies that examined Kv4 and KChIP expression in the hippocampus
of pilocarpine treated mice did not also examine the electrophysiology of the Atype current (Tsaur et al., 1992; Monaghan et al., 2008; Su et al., 2008) and
electrophysiological studies did not also examine gene expression (Bernard et al.,
2004). The 1mm tissue samples that the RNA was isolated from contained the
majority of the vagal complex, including neurons from NTS, DMV, and area
postrema (Bach et al., 2015; Boychuk et al., 2015a; Boychuk et al., 2017).
Although the majority of neurons within the NTS are GABAergic (Chan and
Sawchenko, 1998), the tissue sampling process used in this dissertation inevitably
samples from a heterogeneous cell population. An alternative approach to more
accurately measure Kv4 and KChIP expression includes single cell qRT-PCR
which would allow for differences in expression to be measured from single
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GABAergic NTS neurons, identified by GFP. In the hippocampus, it has been
shown that increased channel phosphorylation via protein kinase C (PKC) in
neurons from TLE mice is associated with altered A-type current excitability
(Bernard et al., 2004). Additionally, biochemical studies have shown that sitedirected mutagenesis of phosphorylation sites on Kv4 channels alters the A-type
current (Nakamura et al., 1997; Schrader et al., 2002). Antibodies have been
developed for several phosphorylation sites on Kv4.2 (Birnbaum et al., 2004), and
could be used to examine differences in the amount of phosphorylated channel in
GABA NTS neurons. Western blotting could also be utilized to determine
differences in phosphorylated Kv4 channel protein compared to total Kv4 channel
protein in control and pilo-SE mice. Overall, more work is necessary to determine
why there is a reduction an IA but no change in RNA expression.
6.5

Chemogenetic modulation of vagal complex neurons in TLE
6.5.1 Activation of GABAergic NTS neurons in whole animals
The use of DREADDs to modify whole animal behavior has become

increasingly popular in studies examining feeding, addiction and anxiety (Whissell
et al., 2016; Roman et al., 2017; Grafe et al., 2018; Ray et al., 2018; Runegaard
et al., 2018; Zhang et al., 2018). This dissertation used an excitatory DREADD that
allowed for the activation of GABAergic NTS neurons via CNO to test the
hypothesis that these neurons were directly involved in seizure activity and
SUDEP. A study using genetic epilepsy models showed that in anesthetized mice,
a pharmacologically induced cortical seizure can spread to the caudal brainstem
resulting in spreading depression and SUDEP (Aiba and Noebels, 2015). This is
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significant because the caudal brainstem contains the NTS, which is directly
implicated in SUDEP because of this study. However, until this dissertation, this
has not been similarly tested in TLE. GABAergic NTS neurons were activated via
i.p. CNO injection 20 minutes prior to the induction of an acute seizure. None of
the animals died from SUDEP. Additionally, CNO did not have an effect on seizure
latency in pilo-SE animals. Interestingly, CNO significantly reduced seizure latency
in control animals. DREADDs-mediated activation of GABAergic NTS neurons
from control mice may have had a greater effect on seizure latency compared to
pilo-SE mice because the control animals never exhibited spontaneous seizures
prior to flurothyl, so they may be more susceptible to the effect of CNO on seizure
latency. Whereas GABAergic NTS neurons from pilo-SE mice are already
hyperexcitable, and therefore CNO may have less of an effect on seizure latency.
This study also shows that DREADDs are capable of modulating seizure activity
in control animals.
This dissertation differed significantly from that of Aiba and Noebels in many
ways. Aiba and Noebels used mouse genetic epilepsy models to determine if
brainstem structures were involved in SUDEP. Using both in vivo and in vitro
techniques, they showed that NTS is particularly susceptible to spreading
depression, ultimately leading to cardiorespiratory collapse and sudden death
(Aiba and Noebels, 2015). In their study a chemoconvulsant was applied directly
to cortical tissue, cortical EEG was measured during this application, and direct
current was recorded in the caudal brainstem. This dissertation used a different
seizure induction method and did not record EEG or brainstem current. However,
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the study by Aiba and Noebels is confounded by their use of genetic epilepsy
models because their results may be due to genetic mutations instead of the
seizures (Aiba and Noebels, 2015). Additionally, while these genetic epilepsy
models have a reduction in Na+ current in regions of the cortex (Yu et al., 2006;
Cheah et al., 2012; Kalume et al., 2013; Ogiwara et al., 2013), this has not been
investigated in NTS neurons.
Interestingly, in the Aiba and Noebels study, when KCl was injected directly
into the NTS, seizure-like waveforms occurred in the cortex (Aiba and Noebels,
2015). The NTS does project to and receive projections from higher brainstem
centers such as the amygdala and hypothalamus (Ricardo and Koh, 1978; van der
Kooy et al., 1984; Takenaka et al., 1995; Fontes et al., 2001; Affleck et al., 2012).
Additionally, changes in NTS neuron activation in response to cortical seizure
activity can occur independently of blood pressure changes, showing that input
from vagal afferents is not necessary for NTS neuron plasticity to occur (Kanter et
al., 1995) . One treatment for refractory epilepsy whose mechanism is poorly
understood but appears to involve these pathways is vagal nerve stimulation
(VNS). VNS consists of a device that is implanted under the chest skin with a wire
attached to the vagus nerve delivering electrical pulses to the nerve preventing
seizures. While successful, it has not been well-established exactly how VNS is
capable of preventing seizures (Uthman, 2000; Howland, 2014; Giordano et al.,
2017). One study has suggested that electrical activation of the NTS attenuates
amygdala-kindled seizures (Magdaleno-Madrigal et al., 2002), however specific
neuronal subtypes were not investigated. This dissertation has shown that NTS
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neurons experience functional changes in association with epileptogenesis, but
this area could also be targeted for potential epilepsy treatments in individuals with
refractory TLE.
In other epilepsy models, inhibitory DREADDs have been utilized to
attenuate seizure activity (Avaliani et al., 2016; Wicker and Forcelli, 2016). In one
study using kindled mice, the dose of CNO that was most effective in reducing
seizure severity was much greater (2.5, 5, and 10 mg/kg) compared to this study
(1 mg/kg) (Wicker and Forcelli, 2016). Additionally, Wicker and Forcelli used a
1mg/kg dose, but it did not significantly suppress seizure severity (Wicker and
Forcelli, 2016).
There are additional concerns regarding the conversion of CNO to
clozapine (MacLaren et al., 2016; Gomez et al., 2017; Raper et al., 2017; Manvich
et al., 2018). CNO is the compounds that binds to and activates DREADDs.
Studies optimizing DREADDs have shown that it is a pharmacologically inert
metabolite of the antipsychotic compound of the drug clozapine (Armbruster et al.,
2007; Roth, 2016). Additionally, while clozapine does have high affinity for
DREADDs, CNO is supposed to have a more potent and therefore efficacious
effect (Armbruster et al., 2007). One caveat to these drug binding studies is that
they were done in yeast cultures and not whole animal systems. The studies
asserting that CNO is reverse metabolized to clozapine, binds to DREADDs
receptors with high affinity, and produces clozapine effects were done using
rodents, which are typically utilized in chemogenetics (Gomez et al., 2017;
Manvich et al., 2018). Additionally, one of the studies showed that clozapine
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crosses the blood brain barrier more effectively then CNO, but the sample sizes
were extremely small, with 2 rats per group (Gomez et al., 2017). However, a
separate study concluded that while CNO metabolizes to clozapine, it does so in
insignificant amounts, and therefore does not have an effect (Guettier et al., 2009).
In a small cohort of animals that did not contain mCherry-expressing GABAergic
NTS neurons, there were no off-target effects of CNO in vitro. However, this was
not tested in the in vivo studies with flurothyl-induced seizures in this dissertation.
Behavioral and motor testing can be done on mice to ensure that CNO does
not produce clozapine-like effects. Antipsychotic agents, such as clozapine, can
cause catalepsy, which is characterized by behavioral immobility and muscle
rigidity. To determine if CNO administration causes a clozapine-like effect on
behavior, the open field test can be used to test for behavioral immobility. If
clozapine-like effects are evident, there should be a decrease in overall movement
in the open field test and periods of immobility where the animal is stationary. This
can also be compared to systemic injection of clozapine and vehicle in mice with
and without DREADDs.
6.5.2 Activation of GABAergic NTS neurons using in vitro slice
electrophysiology
The hypothesis that CNO was able to activate mCherry-expressing
GABAergic neurons and also inhibit downstream vagal motor neurons was tested
in control and pilo-SE mice. CNO application elicited a depolarization in mCherry
expressing neurons from both control and pilo-SE mice. Interestingly, this effect
was slightly stronger in pilo-SE mice, where mCherry-expressing neurons were
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depolarized 2.5% more than neurons from control mice. There was also a
significant increase in action potential frequency in GABAergic NTS neurons from
control and pilo-SE mice. CNO-mediated activation of GABAergic NTS neurons
led to the inhibition of downstream DMV neurons, a portion of which are
preganglionic parasympathetic neurons. DMV neurons from pilo-SE mice were
5.62% more inhibited after mCherry-expressing neuron activation than control
mice. This suggests that GABAergic NTS neurons from pilo-SE mice are 1) more
susceptible to CNO-induced depolarization and 2) their activation leads to
increased downstream inhibition of DMV neurons. These data suggest that piloSE mice have an increased propensity for parasympathetic inhibition upon
activation of GABAergic NTS neurons, which could lead to autonomic balance, one
of the main risk factors for SUDEP.
6.5.3 Future directions
In the future the in vivo studies should be repeated with higher dose of CNO.
In a study using kindling to induce epilepsy combined with an inhibitory DREADD
to silence seizures, a much higher doses of CNO was needed to reduce seizure
severity compared this dissertation (Wicker and Forcelli, 2016). Additionally, CNO
was dissolved at a much higher concentration in the aforementioned study
compared to the in vivo seizure induction in this dissertation (Wicker and Forcelli,
2016). The dose and concentration of CNO in this dissertation were chosen were
based on efficacy in previously published studies and to minimize potential
conversion of CNO to clozapine (Guettier et al., 2009). Perhaps modifying the
concentration and dosing of CNO would elicit alterations in seizure behavior.
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To avoid an effect of the flurothyl treatment, alternative methods similar to
that of Aiba and Noebels could be used to elicit a seizure (Aiba and Noebels,
2015). One option would be to apply a chemoconvulsant, such as 4-AP directly to
cortical tissue and measure brainstem currents. Another option includes
microinjection of KCl into the brainstem to elicit spreading depression in an
anesthetized animal after i.p. injection of CNO. In this case it could be determined
if CNO causes a pilo-SE animal to develop spreading depression more quickly
than without CNO and compared to control animals in the same conditions. This
has technique has been used successfully by others to elicit spreading depression
in both the cortex and brainstem (Aiba and Noebels, 2015; Nasretdinov et al.,
2017).
6.6

Summary
While potential mechanisms of SUDEP have been heavily studied in genetic

epilepsy models (Glasscock et al., 2010; Cheah et al., 2012; Auerbach et al., 2013;
Kalume et al., 2013; Aiba and Noebels, 2015), this dissertation is the first to do so
in a mouse model of TLE, which is a model of acquired epilepsy. This is impactful
on the field since over 50% of individuals with epilepsy have TLE and over half of
those are at high risk for SUDEP, compared to the 1-2% of individuals that have
genetic epilepsies. Genetic epilepsies also tend to be more severe and have more
comorbidities than those with TLE. This dissertation was the first to show that TLE
mice die from SUDEP and that functional changes in GABAergic NTS neurons
occur in response to pilocarpine-induced TLE. These neurons are crucial
integrators of cardiorespiratory information and modulators of peripheral output of
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parasympathetic tone, impacting autonomic balance. This dissertation has shown
that these neurons develop an increase in excitability, which in part is due to a
reduction in the A-type K+ current. However, this study did not find that
chemogenetic activation of GABAergic NTS neurons could directly lead to a
seizure or SUDEP in this mode. The exact role that these changes play in SUDEP
in TLE remains to be elucidated and SUDEP in this model is most likely due to a
combination of factors including alterations in autonomic, cardiac, and respiratory
systems.
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Appendix
Appendix 1.1 Electrophysiology Recording Setup
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